files.nhpri.org - /Wordpress/Nhpri_uploads/2020/08/
[To Parent Directory]
8/14/2025 1:56 PM 5970 2019-QI-Annual-Evaluation-Executive-Summary-pdf-116x150.jpg
8/14/2025 1:56 PM 8596 2019-QI-Annual-Evaluation-Executive-Summary-pdf-232x300.jpg
8/14/2025 1:56 PM 34013 2019-QI-Annual-Evaluation-Executive-Summary-pdf-791x1024.jpg
8/14/2025 1:56 PM 44293 2019-QI-Annual-Evaluation-Executive-Summary-pdf.jpg
8/14/2025 1:56 PM 292999 2019-QI-Annual-Evaluation-Executive-Summary.pdf
8/14/2025 1:56 PM 7241 2020-Medicare-Step-Therapy-Posting-8.15.20-pdf-116x150.jpg
8/14/2025 1:56 PM 19701 2020-Medicare-Step-Therapy-Posting-8.15.20-pdf-232x300.jpg
8/14/2025 1:56 PM 142586 2020-Medicare-Step-Therapy-Posting-8.15.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 201338 2020-Medicare-Step-Therapy-Posting-8.15.20-pdf.jpg
8/14/2025 1:56 PM 417411 2020-Medicare-Step-Therapy-Posting-8.15.20.pdf
8/14/2025 1:56 PM 7276 2020-Quality-Improvement-Program-Description-Final-pdf-116x150.jpg
8/14/2025 1:56 PM 15574 2020-Quality-Improvement-Program-Description-Final-pdf-232x300.jpg
8/14/2025 1:56 PM 92363 2020-Quality-Improvement-Program-Description-Final-pdf-791x1024.jpg
8/14/2025 1:56 PM 135917 2020-Quality-Improvement-Program-Description-Final-pdf.jpg
8/14/2025 1:56 PM 1442886 2020-Quality-Improvement-Program-Description-Final.pdf
8/14/2025 1:56 PM 6397 2020_CPG_Prenatal-pdf-116x150.jpg
8/14/2025 1:56 PM 14857 2020_CPG_Prenatal-pdf-232x300.jpg
8/14/2025 1:56 PM 104915 2020_CPG_Prenatal-pdf-791x1024.jpg
8/14/2025 1:56 PM 158636 2020_CPG_Prenatal-pdf.jpg
8/14/2025 1:56 PM 257449 2020_CPG_Prenatal.pdf
8/14/2025 1:56 PM 31952 2022_CPG_ADHD.pdf
8/14/2025 1:56 PM 110885 2022_CPG_Pediatric-Preventative.pdf
8/14/2025 1:56 PM 7882 Actemra_CMP_Non-ONC.7.28.20-1-pdf-116x150.jpg
8/14/2025 1:56 PM 20585 Actemra_CMP_Non-ONC.7.28.20-1-pdf-232x300.jpg
8/14/2025 1:56 PM 145705 Actemra_CMP_Non-ONC.7.28.20-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 212866 Actemra_CMP_Non-ONC.7.28.20-1-pdf.jpg
8/14/2025 1:56 PM 399979 Actemra_CMP_Non-ONC.7.28.20-1.pdf
8/14/2025 1:56 PM 7882 Actemra_CMP_Non-ONC.7.28.20-pdf-116x150.jpg
8/14/2025 1:56 PM 20585 Actemra_CMP_Non-ONC.7.28.20-pdf-232x300.jpg
8/14/2025 1:56 PM 145705 Actemra_CMP_Non-ONC.7.28.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 212866 Actemra_CMP_Non-ONC.7.28.20-pdf.jpg
8/14/2025 1:56 PM 399979 Actemra_CMP_Non-ONC.7.28.20.pdf
8/14/2025 1:56 PM 4144 Alecensa-2150-A-SGM-P2020-pdf-116x150.jpg
8/14/2025 1:56 PM 5848 Alecensa-2150-A-SGM-P2020-pdf-232x300.jpg
8/14/2025 1:56 PM 16818 Alecensa-2150-A-SGM-P2020-pdf-791x1024.jpg
8/14/2025 1:56 PM 21709 Alecensa-2150-A-SGM-P2020-pdf.jpg
8/14/2025 1:56 PM 115619 Alecensa-2150-A-SGM-P2020.pdf
8/14/2025 1:56 PM 6925 Aranesp.criteria.nononc.7.15-pdf-116x150.jpg
8/14/2025 1:56 PM 17236 Aranesp.criteria.nononc.7.15-pdf-232x300.jpg
8/14/2025 1:56 PM 123627 Aranesp.criteria.nononc.7.15-pdf-791x1024.jpg
8/14/2025 1:56 PM 186849 Aranesp.criteria.nononc.7.15-pdf.jpg
8/14/2025 1:56 PM 300297 Aranesp.criteria.nononc.7.15.pdf
8/14/2025 1:56 PM 100199 Authorization_Guide_HBE-8-1-pdf-1024x791.jpg
8/14/2025 1:56 PM 7584 Authorization_Guide_HBE-8-1-pdf-150x116.jpg
8/14/2025 1:56 PM 17472 Authorization_Guide_HBE-8-1-pdf-300x232.jpg
8/14/2025 1:56 PM 145812 Authorization_Guide_HBE-8-1-pdf.jpg
8/14/2025 1:56 PM 656970 Authorization_Guide_HBE-8-1.pdf
8/14/2025 1:56 PM 100199 Authorization_Guide_HBE-8-pdf-1024x791.jpg
8/14/2025 1:56 PM 7584 Authorization_Guide_HBE-8-pdf-150x116.jpg
8/14/2025 1:56 PM 17472 Authorization_Guide_HBE-8-pdf-300x232.jpg
8/14/2025 1:56 PM 145812 Authorization_Guide_HBE-8-pdf.jpg
8/14/2025 1:56 PM 656970 Authorization_Guide_HBE-8.pdf
8/14/2025 1:56 PM 109164 Authorization_Guide_INTEGRITY-8.31.20-1-pdf-1024x791.jpg
8/14/2025 1:56 PM 7786 Authorization_Guide_INTEGRITY-8.31.20-1-pdf-150x116.jpg
8/14/2025 1:56 PM 19129 Authorization_Guide_INTEGRITY-8.31.20-1-pdf-300x232.jpg
8/14/2025 1:56 PM 161127 Authorization_Guide_INTEGRITY-8.31.20-1-pdf.jpg
8/14/2025 1:56 PM 765975 Authorization_Guide_INTEGRITY-8.31.20-1.pdf
8/14/2025 1:56 PM 109164 Authorization_Guide_INTEGRITY-8.31.20-pdf-1024x791.jpg
8/14/2025 1:56 PM 7786 Authorization_Guide_INTEGRITY-8.31.20-pdf-150x116.jpg
8/14/2025 1:56 PM 19129 Authorization_Guide_INTEGRITY-8.31.20-pdf-300x232.jpg
8/14/2025 1:56 PM 161127 Authorization_Guide_INTEGRITY-8.31.20-pdf.jpg
8/14/2025 1:56 PM 765975 Authorization_Guide_INTEGRITY-8.31.20.pdf
8/14/2025 1:56 PM 109596 Authorization_Guide_RHP-8.31.20-1-pdf-1024x791.jpg
8/14/2025 1:56 PM 7433 Authorization_Guide_RHP-8.31.20-1-pdf-150x116.jpg
8/14/2025 1:56 PM 18637 Authorization_Guide_RHP-8.31.20-1-pdf-300x232.jpg
8/14/2025 1:56 PM 157738 Authorization_Guide_RHP-8.31.20-1-pdf.jpg
8/14/2025 1:56 PM 674949 Authorization_Guide_RHP-8.31.20-1.pdf
8/14/2025 1:56 PM 109596 Authorization_Guide_RHP-8.31.20-pdf-1024x791.jpg
8/14/2025 1:56 PM 7433 Authorization_Guide_RHP-8.31.20-pdf-150x116.jpg
8/14/2025 1:56 PM 18637 Authorization_Guide_RHP-8.31.20-pdf-300x232.jpg
8/14/2025 1:56 PM 157738 Authorization_Guide_RHP-8.31.20-pdf.jpg
8/14/2025 1:56 PM 674949 Authorization_Guide_RHP-8.31.20.pdf
8/14/2025 1:56 PM 102063 Authorization_Guide_RIteCare-8.31.20-1-pdf-1024x791.jpg
8/14/2025 1:56 PM 7674 Authorization_Guide_RIteCare-8.31.20-1-pdf-150x116.jpg
8/14/2025 1:56 PM 18068 Authorization_Guide_RIteCare-8.31.20-1-pdf-300x232.jpg
8/14/2025 1:56 PM 151521 Authorization_Guide_RIteCare-8.31.20-1-pdf.jpg
8/14/2025 1:56 PM 675817 Authorization_Guide_RIteCare-8.31.20-1.pdf
8/14/2025 1:56 PM 102063 Authorization_Guide_RIteCare-8.31.20-pdf-1024x791.jpg
8/14/2025 1:56 PM 7674 Authorization_Guide_RIteCare-8.31.20-pdf-150x116.jpg
8/14/2025 1:56 PM 18068 Authorization_Guide_RIteCare-8.31.20-pdf-300x232.jpg
8/14/2025 1:56 PM 151521 Authorization_Guide_RIteCare-8.31.20-pdf.jpg
8/14/2025 1:56 PM 675817 Authorization_Guide_RIteCare-8.31.20.pdf
8/14/2025 1:56 PM 5515 Brachytherapy-Oncology-Applications-UM-XRT_2002-pdf-116x150.jpg
8/14/2025 1:56 PM 7605 Brachytherapy-Oncology-Applications-UM-XRT_2002-pdf-232x300.jpg
8/14/2025 1:56 PM 24683 Brachytherapy-Oncology-Applications-UM-XRT_2002-pdf-791x1024.jpg
8/14/2025 1:56 PM 32221 Brachytherapy-Oncology-Applications-UM-XRT_2002-pdf.jpg
8/14/2025 1:56 PM 349584 Brachytherapy-Oncology-Applications-UM-XRT_2002.pdf
8/14/2025 1:56 PM 7838 CMP_Rituxan_NonOnc_20210128-pdf-116x150.jpg
8/14/2025 1:56 PM 20700 CMP_Rituxan_NonOnc_20210128-pdf-232x300.jpg
8/14/2025 1:56 PM 150019 CMP_Rituxan_NonOnc_20210128-pdf-791x1024.jpg
8/14/2025 1:56 PM 226583 CMP_Rituxan_NonOnc_20210128-pdf.jpg
8/14/2025 1:56 PM 343567 CMP_Rituxan_NonOnc_20210128.pdf
8/14/2025 1:56 PM 7846 CMP_Soliris_20201130-pdf-116x150.jpg
8/14/2025 1:56 PM 21007 CMP_Soliris_20201130-pdf-232x300.jpg
8/14/2025 1:56 PM 141185 CMP_Soliris_20201130-pdf-791x1024.jpg
8/14/2025 1:56 PM 207432 CMP_Soliris_20201130-pdf.jpg
8/14/2025 1:56 PM 343532 CMP_Soliris_20201130.pdf
8/14/2025 1:56 PM 6907 Dronabinol_NO_Criteria_2.24.20-pdf-116x150.jpg
8/14/2025 1:56 PM 15071 Dronabinol_NO_Criteria_2.24.20-pdf-232x300.jpg
8/14/2025 1:56 PM 104161 Dronabinol_NO_Criteria_2.24.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 159928 Dronabinol_NO_Criteria_2.24.20-pdf.jpg
8/14/2025 1:56 PM 103335 Dronabinol_NO_Criteria_2.24.20.pdf
8/14/2025 1:56 PM 4055 Eligard-1966-A-2084-A-SGM-P2020-pdf-116x150.jpg
8/14/2025 1:56 PM 5676 Eligard-1966-A-2084-A-SGM-P2020-pdf-232x300.jpg
8/14/2025 1:56 PM 16516 Eligard-1966-A-2084-A-SGM-P2020-pdf-791x1024.jpg
8/14/2025 1:56 PM 21606 Eligard-1966-A-2084-A-SGM-P2020-pdf.jpg
8/14/2025 1:56 PM 140021 Eligard-1966-A-2084-A-SGM-P2020.pdf
8/14/2025 1:56 PM 3313801 English-Social-Media-Images.zip
8/14/2025 1:56 PM 7700 Epogen-Procrit-Retacrit.nononcology-criteria.11.19.20-pdf-116x150.jpg
8/14/2025 1:56 PM 20257 Epogen-Procrit-Retacrit.nononcology-criteria.11.19.20-pdf-232x300.jpg
8/14/2025 1:56 PM 156812 Epogen-Procrit-Retacrit.nononcology-criteria.11.19.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 239092 Epogen-Procrit-Retacrit.nononcology-criteria.11.19.20-pdf.jpg
8/14/2025 1:56 PM 276560 Epogen-Procrit-Retacrit.nononcology-criteria.11.19.20.pdf
8/14/2025 1:56 PM 7697 Epogen-Procrit-Retacrit.nononcology-NO_criteria.7.9.20-pdf-116x150.jpg
8/14/2025 1:56 PM 19735 Epogen-Procrit-Retacrit.nononcology-NO_criteria.7.9.20-pdf-232x300.jpg
8/14/2025 1:56 PM 156489 Epogen-Procrit-Retacrit.nononcology-NO_criteria.7.9.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 245555 Epogen-Procrit-Retacrit.nononcology-NO_criteria.7.9.20-pdf.jpg
8/14/2025 1:56 PM 276416 Epogen-Procrit-Retacrit.nononcology-NO_criteria.7.9.20.pdf
8/14/2025 1:56 PM 8097 ESA_agents_Aranesp_Epogen_Procrit_Retacrit_Non-Onc.7.28.20-pdf-116x150.jpg
8/14/2025 1:56 PM 22320 ESA_agents_Aranesp_Epogen_Procrit_Retacrit_Non-Onc.7.28.20-pdf-232x300.jpg
8/14/2025 1:56 PM 175886 ESA_agents_Aranesp_Epogen_Procrit_Retacrit_Non-Onc.7.28.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 254781 ESA_agents_Aranesp_Epogen_Procrit_Retacrit_Non-Onc.7.28.20-pdf.jpg
8/14/2025 1:56 PM 553472 ESA_agents_Aranesp_Epogen_Procrit_Retacrit_Non-Onc.7.28.20.pdf
8/14/2025 1:56 PM 4055 EXC_eligard_20201001-pdf-116x150.jpg
8/14/2025 1:56 PM 5676 EXC_eligard_20201001-pdf-232x300.jpg
8/14/2025 1:56 PM 16516 EXC_eligard_20201001-pdf-791x1024.jpg
8/14/2025 1:56 PM 21606 EXC_eligard_20201001-pdf.jpg
8/14/2025 1:56 PM 138794 EXC_eligard_20201001.pdf
8/14/2025 1:56 PM 4055 EXC_Lupron_-Depot_PED_20201001-pdf-116x150.jpg
8/14/2025 1:56 PM 5676 EXC_Lupron_-Depot_PED_20201001-pdf-232x300.jpg
8/14/2025 1:56 PM 16516 EXC_Lupron_-Depot_PED_20201001-pdf-791x1024.jpg
8/14/2025 1:56 PM 21606 EXC_Lupron_-Depot_PED_20201001-pdf.jpg
8/14/2025 1:56 PM 132510 EXC_Lupron_-Depot_PED_20201001.pdf
8/14/2025 1:56 PM 7800 Exchange-6T-September2020-pdf-116x150.jpg
8/14/2025 1:56 PM 21116 Exchange-6T-September2020-pdf-232x300.jpg
8/14/2025 1:56 PM 174131 Exchange-6T-September2020-pdf-791x1024.jpg
8/14/2025 1:56 PM 256504 Exchange-6T-September2020-pdf.jpg
8/14/2025 1:56 PM 528771 Exchange-6T-September2020.pdf
8/27/2020 3:06 PM 11061 export-media-urls-112450.CSV
8/18/2020 8:42 PM 20078 export-media-urls-345753.CSV
8/14/2025 1:56 PM 35351 export-media-urls-428749.CSV
8/14/2025 1:56 PM 54680 export-media-urls-438551.CSV
8/27/2020 3:06 PM 203174 export-media-urls-794831.CSV
8/18/2020 8:34 PM 142782 export-media-urls-891558.CSV
8/18/2020 8:35 PM 183142 export-media-urls-984150.CSV
8/14/2025 1:56 PM 9680 External-Beam-Teletherapy-UM-XRT_2001-pdf-116x150.jpg
8/14/2025 1:56 PM 25466 External-Beam-Teletherapy-UM-XRT_2001-pdf-232x300.jpg
8/14/2025 1:56 PM 217475 External-Beam-Teletherapy-UM-XRT_2001-pdf-791x1024.jpg
8/14/2025 1:56 PM 331800 External-Beam-Teletherapy-UM-XRT_2001-pdf.jpg
8/14/2025 1:56 PM 403873 External-Beam-Teletherapy-UM-XRT_2001.pdf
8/14/2025 1:56 PM 5232 Genomic-Genetic-Biomarker-Testing-UM-ONC_1394-pdf-116x150.jpg
8/14/2025 1:56 PM 7328 Genomic-Genetic-Biomarker-Testing-UM-ONC_1394-pdf-232x300.jpg
8/14/2025 1:56 PM 25212 Genomic-Genetic-Biomarker-Testing-UM-ONC_1394-pdf-791x1024.jpg
8/14/2025 1:56 PM 32354 Genomic-Genetic-Biomarker-Testing-UM-ONC_1394-pdf.jpg
8/14/2025 1:56 PM 205802 Genomic-Genetic-Biomarker-Testing-UM-ONC_1394.pdf
8/14/2025 1:56 PM 25213 Image-Guided-Radiation-Therapy-UM-XRT_2004-pdf-116x150.jpg
8/14/2025 1:56 PM 42217 Image-Guided-Radiation-Therapy-UM-XRT_2004-pdf-232x300.jpg
8/14/2025 1:56 PM 234470 Image-Guided-Radiation-Therapy-UM-XRT_2004-pdf-791x1024.jpg
8/14/2025 1:56 PM 345246 Image-Guided-Radiation-Therapy-UM-XRT_2004-pdf.jpg
8/14/2025 1:56 PM 344627 Image-Guided-Radiation-Therapy-UM-XRT_2004.pdf
8/14/2025 1:56 PM 12199434 Immunization-Community-Toolkit.zip
8/14/2025 1:56 PM 14381 Immunization-Flyer-English-pdf-116x150.jpg
8/14/2025 1:56 PM 39523 Immunization-Flyer-English-pdf-232x300.jpg
8/14/2025 1:56 PM 253857 Immunization-Flyer-English-pdf-791x1024.jpg
8/14/2025 1:56 PM 338845 Immunization-Flyer-English-pdf.jpg
8/14/2025 1:56 PM 680179 Immunization-Flyer-English.pdf
8/14/2025 1:56 PM 14586 Immunization-Flyer-Portuguese-pdf-116x150.jpg
8/14/2025 1:56 PM 42645 Immunization-Flyer-Portuguese-pdf-232x300.jpg
8/14/2025 1:56 PM 281329 Immunization-Flyer-Portuguese-pdf-791x1024.jpg
8/14/2025 1:56 PM 374091 Immunization-Flyer-Portuguese-pdf.jpg
8/14/2025 1:56 PM 681066 Immunization-Flyer-Portuguese.pdf
8/14/2025 1:56 PM 14609 Immunization-Flyer-Spanish-pdf-116x150.jpg
8/14/2025 1:56 PM 41649 Immunization-Flyer-Spanish-pdf-232x300.jpg
8/14/2025 1:56 PM 276764 Immunization-Flyer-Spanish-pdf-791x1024.jpg
8/14/2025 1:56 PM 376076 Immunization-Flyer-Spanish-pdf.jpg
8/14/2025 1:56 PM 680655 Immunization-Flyer-Spanish.pdf
8/14/2025 1:56 PM 4119 Inlyta-2079-A-SGM-P2019a-pdf-116x150.jpg
8/14/2025 1:56 PM 5552 Inlyta-2079-A-SGM-P2019a-pdf-232x300.jpg
8/14/2025 1:56 PM 16496 Inlyta-2079-A-SGM-P2019a-pdf-791x1024.jpg
8/14/2025 1:56 PM 22288 Inlyta-2079-A-SGM-P2019a-pdf.jpg
8/14/2025 1:56 PM 30911 Inlyta-2079-A-SGM-P2019a.pdf
8/14/2025 1:56 PM 4570 Intensity-Modulated-Radiation-Therapy-UM-XRT_2003-pdf-116x150.jpg
8/14/2025 1:56 PM 6636 Intensity-Modulated-Radiation-Therapy-UM-XRT_2003-pdf-232x300.jpg
8/14/2025 1:56 PM 24496 Intensity-Modulated-Radiation-Therapy-UM-XRT_2003-pdf-791x1024.jpg
8/14/2025 1:56 PM 31121 Intensity-Modulated-Radiation-Therapy-UM-XRT_2003-pdf.jpg
8/14/2025 1:56 PM 295598 Intensity-Modulated-Radiation-Therapy-UM-XRT_2003.pdf
8/14/2025 1:56 PM 243587 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-1024x1536.jpg
8/14/2025 1:56 PM 442955 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-1365x2048.jpg
8/14/2025 1:56 PM 5852 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-150x150.jpg
8/14/2025 1:56 PM 11985 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-200x300.jpg
8/14/2025 1:56 PM 37124 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-500x400.jpg
8/14/2025 1:56 PM 106649 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-682x1024.jpg
8/14/2025 1:56 PM 134399 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-768x1152.jpg
8/14/2025 1:56 PM 61768 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-e1598561966778-500x400.jpg
8/14/2025 1:56 PM 22567 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-SM-150x150.jpg
8/14/2025 1:56 PM 29180 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-SM-200x300.jpg
8/14/2025 1:56 PM 45025 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-SM-300x400.jpg
8/14/2025 1:56 PM 35135 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-SM-e1598562530187.jpg
8/14/2025 1:56 PM 22705 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-SM-e1598562594356-150x150.jpg
8/14/2025 1:56 PM 32150 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-SM-e1598562594356.jpg
8/14/2025 1:56 PM 63435 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB-SM.jpg
8/14/2025 1:56 PM 553107 LeslieTaito_Neighborhood_StephanieEwensPhotography20200814_2.5MB.jpg
8/14/2025 1:56 PM 8126 Long-acting-CSF_CMP_-Non-Onc.-8.17.20-pdf-116x150.jpg
8/14/2025 1:56 PM 21947 Long-acting-CSF_CMP_-Non-Onc.-8.17.20-pdf-232x300.jpg
8/14/2025 1:56 PM 168313 Long-acting-CSF_CMP_-Non-Onc.-8.17.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 253532 Long-acting-CSF_CMP_-Non-Onc.-8.17.20-pdf.jpg
8/14/2025 1:56 PM 311265 Long-acting-CSF_CMP_-Non-Onc.-8.17.20.pdf
8/14/2025 1:56 PM 4055 Lupron-Depot-PED-1972-A-2077-A-SGM-P2020a-pdf-116x150.jpg
8/14/2025 1:56 PM 5676 Lupron-Depot-PED-1972-A-2077-A-SGM-P2020a-pdf-232x300.jpg
8/14/2025 1:56 PM 16516 Lupron-Depot-PED-1972-A-2077-A-SGM-P2020a-pdf-791x1024.jpg
8/14/2025 1:56 PM 21606 Lupron-Depot-PED-1972-A-2077-A-SGM-P2020a-pdf.jpg
8/14/2025 1:56 PM 141306 Lupron-Depot-PED-1972-A-2077-A-SGM-P2020a.pdf
8/14/2025 1:56 PM 8723 Medicaid-NOC-September2020-pdf-116x150.jpg
8/14/2025 1:56 PM 26875 Medicaid-NOC-September2020-pdf-232x300.jpg
8/14/2025 1:56 PM 240651 Medicaid-NOC-September2020-pdf-791x1024.jpg
8/14/2025 1:56 PM 361585 Medicaid-NOC-September2020-pdf.jpg
8/14/2025 1:56 PM 661674 Medicaid-NOC-September2020.pdf
8/14/2025 1:56 PM 8521 Medical-Policy-Diabetic-Test-Strips-8.4.20-pdf-116x150.jpg
8/14/2025 1:56 PM 22928 Medical-Policy-Diabetic-Test-Strips-8.4.20-pdf-232x300.jpg
8/14/2025 1:56 PM 169110 Medical-Policy-Diabetic-Test-Strips-8.4.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 252506 Medical-Policy-Diabetic-Test-Strips-8.4.20-pdf.jpg
8/14/2025 1:56 PM 569354 Medical-Policy-Diabetic-Test-Strips-8.4.20.pdf
8/14/2025 1:56 PM 4055 Mitoxantrone-1662-A-SGM-P2020-pdf-116x150.jpg
8/14/2025 1:56 PM 5676 Mitoxantrone-1662-A-SGM-P2020-pdf-232x300.jpg
8/14/2025 1:56 PM 16516 Mitoxantrone-1662-A-SGM-P2020-pdf-791x1024.jpg
8/14/2025 1:56 PM 21606 Mitoxantrone-1662-A-SGM-P2020-pdf.jpg
8/14/2025 1:56 PM 236537 Mitoxantrone-1662-A-SGM-P2020.pdf
8/14/2025 1:56 PM 207956 MMP-NOC-September2020-pdf-1024x791.jpg
8/14/2025 1:56 PM 8635 MMP-NOC-September2020-pdf-150x116.jpg
8/14/2025 1:56 PM 25226 MMP-NOC-September2020-pdf-300x232.jpg
8/14/2025 1:56 PM 302134 MMP-NOC-September2020-pdf.jpg
8/14/2025 1:56 PM 207375 MMP-NOC-September2020.pdf
8/14/2025 1:56 PM 11519 MMP-September-English-pdf-116x150.jpg
8/14/2025 1:56 PM 29221 MMP-September-English-pdf-232x300.jpg
8/14/2025 1:56 PM 190282 MMP-September-English-pdf-791x1024.jpg
8/14/2025 1:56 PM 255385 MMP-September-English-pdf.jpg
8/14/2025 1:56 PM 2648940 MMP-September-English.pdf
8/14/2025 1:56 PM 11537 MMP-September-PTG-pdf-116x150.jpg
8/14/2025 1:56 PM 29228 MMP-September-PTG-pdf-232x300.jpg
8/14/2025 1:56 PM 187031 MMP-September-PTG-pdf-791x1024.jpg
8/14/2025 1:56 PM 254797 MMP-September-PTG-pdf.jpg
8/14/2025 1:56 PM 2622804 MMP-September-PTG.pdf
8/14/2025 1:56 PM 11244 MMP-September-Spanish-pdf-116x150.jpg
8/14/2025 1:56 PM 28504 MMP-September-Spanish-pdf-232x300.jpg
8/14/2025 1:56 PM 193897 MMP-September-Spanish-pdf-791x1024.jpg
8/14/2025 1:56 PM 259095 MMP-September-Spanish-pdf.jpg
8/14/2025 1:56 PM 2644046 MMP-September-Spanish.pdf
8/14/2025 1:56 PM 7837 MRxM_Vyepti_07_20V2-pdf-116x150.jpg
8/14/2025 1:56 PM 20431 MRxM_Vyepti_07_20V2-pdf-232x300.jpg
8/14/2025 1:56 PM 149547 MRxM_Vyepti_07_20V2-pdf-791x1024.jpg
8/14/2025 1:56 PM 214624 MRxM_Vyepti_07_20V2-pdf.jpg
8/14/2025 1:56 PM 716936 MRxM_Vyepti_07_20V2.pdf
8/14/2025 1:56 PM 7845 MRxM_Vyepti_09_20-pdf-116x150.jpg
8/14/2025 1:56 PM 20523 MRxM_Vyepti_09_20-pdf-232x300.jpg
8/14/2025 1:56 PM 150858 MRxM_Vyepti_09_20-pdf-791x1024.jpg
8/14/2025 1:56 PM 216841 MRxM_Vyepti_09_20-pdf.jpg
8/14/2025 1:56 PM 744880 MRxM_Vyepti_09_20.pdf
8/14/2025 1:56 PM 5355 Multiple-Procedure-Payment-Policy-11.01.20-pdf-116x150.jpg
8/14/2025 1:56 PM 9429 Multiple-Procedure-Payment-Policy-11.01.20-pdf-232x300.jpg
8/14/2025 1:56 PM 44727 Multiple-Procedure-Payment-Policy-11.01.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 58138 Multiple-Procedure-Payment-Policy-11.01.20-pdf.jpg
8/14/2025 1:56 PM 372182 Multiple-Procedure-Payment-Policy-11.01.20.pdf
8/14/2025 1:56 PM 25122 Neutron-Beam-Therapy-UM-XRT_2008-pdf-116x150.jpg
8/14/2025 1:56 PM 41447 Neutron-Beam-Therapy-UM-XRT_2008-pdf-232x300.jpg
8/14/2025 1:56 PM 231444 Neutron-Beam-Therapy-UM-XRT_2008-pdf-791x1024.jpg
8/14/2025 1:56 PM 344153 Neutron-Beam-Therapy-UM-XRT_2008-pdf.jpg
8/14/2025 1:56 PM 302099 Neutron-Beam-Therapy-UM-XRT_2008.pdf
8/14/2025 1:56 PM 379534 Out-of-Network-Prior-Authorization-.pdf
8/14/2025 1:56 PM 4466 Out-of-Network-Prior-Authorization-pdf-116x150.jpg
8/14/2025 1:56 PM 6679 Out-of-Network-Prior-Authorization-pdf-232x300.jpg
8/14/2025 1:56 PM 23486 Out-of-Network-Prior-Authorization-pdf-791x1024.jpg
8/14/2025 1:56 PM 31820 Out-of-Network-Prior-Authorization-pdf.jpg
8/14/2025 1:56 PM 377367 Out-of-Network-Prior-Authorization.pdf
8/14/2025 1:56 PM 5268 Outpatient-Physical-and-Occupational-Rehabilitation-Services-Payment-Policy10.01.20-pdf-116x150.jpg
8/14/2025 1:56 PM 9451 Outpatient-Physical-and-Occupational-Rehabilitation-Services-Payment-Policy10.01.20-pdf-232x300.jpg
8/14/2025 1:56 PM 46092 Outpatient-Physical-and-Occupational-Rehabilitation-Services-Payment-Policy10.01.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 60512 Outpatient-Physical-and-Occupational-Rehabilitation-Services-Payment-Policy10.01.20-pdf.jpg
8/14/2025 1:56 PM 545982 Outpatient-Physical-and-Occupational-Rehabilitation-Services-Payment-Policy10.01.20.pdf
8/14/2025 1:56 PM 4066 Pegasys-2139-A-SGM-P2020-pdf-116x150.jpg
8/14/2025 1:56 PM 5604 Pegasys-2139-A-SGM-P2020-pdf-232x300.jpg
8/14/2025 1:56 PM 16566 Pegasys-2139-A-SGM-P2020-pdf-791x1024.jpg
8/14/2025 1:56 PM 21546 Pegasys-2139-A-SGM-P2020-pdf.jpg
8/14/2025 1:56 PM 143799 Pegasys-2139-A-SGM-P2020.pdf
8/14/2025 1:56 PM 3350057 Portuguese-Social-Media-Images.zip
8/14/2025 1:56 PM 6329 Prior-Authorization-Global-Criteria.07.20V2-pdf-116x150.jpg
8/14/2025 1:56 PM 14999 Prior-Authorization-Global-Criteria.07.20V2-pdf-232x300.jpg
8/14/2025 1:56 PM 118254 Prior-Authorization-Global-Criteria.07.20V2-pdf-791x1024.jpg
8/14/2025 1:56 PM 171627 Prior-Authorization-Global-Criteria.07.20V2-pdf.jpg
8/14/2025 1:56 PM 73787 Prior-Authorization-Global-Criteria.07.20V2.pdf
8/14/2025 1:56 PM 25130 Proton-Beam-Therapy-UM-XRT_2007-pdf-116x150.jpg
8/14/2025 1:56 PM 41340 Proton-Beam-Therapy-UM-XRT_2007-pdf-232x300.jpg
8/14/2025 1:56 PM 223593 Proton-Beam-Therapy-UM-XRT_2007-pdf-791x1024.jpg
8/14/2025 1:56 PM 335969 Proton-Beam-Therapy-UM-XRT_2007-pdf.jpg
8/14/2025 1:56 PM 358508 Proton-Beam-Therapy-UM-XRT_2007.pdf
8/14/2025 1:56 PM 5300 Provider-Alert_SSC_Delay8.21.2020-pdf-116x150.jpg
8/14/2025 1:56 PM 10848 Provider-Alert_SSC_Delay8.21.2020-pdf-232x300.jpg
8/14/2025 1:56 PM 69850 Provider-Alert_SSC_Delay8.21.2020-pdf-791x1024.jpg
8/14/2025 1:56 PM 98624 Provider-Alert_SSC_Delay8.21.2020-pdf.jpg
8/14/2025 1:56 PM 316373 Provider-Alert_SSC_Delay8.21.2020.pdf
8/14/2025 1:56 PM 11338 ProviderDirectory_Medicare_English_Tagged_20200718_22000038-pdf-116x150.jpg
8/14/2025 1:56 PM 26775 ProviderDirectory_Medicare_English_Tagged_20200718_22000038-pdf-232x300.jpg
8/14/2025 1:56 PM 163544 ProviderDirectory_Medicare_English_Tagged_20200718_22000038-pdf-791x1024.jpg
8/14/2025 1:56 PM 227969 ProviderDirectory_Medicare_English_Tagged_20200718_22000038-pdf.jpg
8/14/2025 1:56 PM 141524171 ProviderDirectory_Medicare_English_Tagged_20200718_22000038.pdf
8/14/2025 1:56 PM 11338 ProviderDirectory_Medicare_Portuguese_Tagged_20200718_22000038-pdf-116x150.jpg
8/14/2025 1:56 PM 26775 ProviderDirectory_Medicare_Portuguese_Tagged_20200718_22000038-pdf-232x300.jpg
8/14/2025 1:56 PM 163544 ProviderDirectory_Medicare_Portuguese_Tagged_20200718_22000038-pdf-791x1024.jpg
8/14/2025 1:56 PM 227969 ProviderDirectory_Medicare_Portuguese_Tagged_20200718_22000038-pdf.jpg
8/14/2025 1:56 PM 141703863 ProviderDirectory_Medicare_Portuguese_Tagged_20200718_22000038.pdf
8/14/2025 1:56 PM 11338 ProviderDirectory_Medicare_Spanish_Tagged_20200718_22000038-pdf-116x150.jpg
8/14/2025 1:56 PM 26775 ProviderDirectory_Medicare_Spanish_Tagged_20200718_22000038-pdf-232x300.jpg
8/14/2025 1:56 PM 163544 ProviderDirectory_Medicare_Spanish_Tagged_20200718_22000038-pdf-791x1024.jpg
8/14/2025 1:56 PM 227969 ProviderDirectory_Medicare_Spanish_Tagged_20200718_22000038-pdf.jpg
8/14/2025 1:56 PM 141267284 ProviderDirectory_Medicare_Spanish_Tagged_20200718_22000038.pdf
8/14/2025 1:56 PM 7750 Rituxan_CMP_NonOnc.8.17.20-pdf-116x150.jpg
8/14/2025 1:56 PM 19835 Rituxan_CMP_NonOnc.8.17.20-pdf-232x300.jpg
8/14/2025 1:56 PM 146100 Rituxan_CMP_NonOnc.8.17.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 217239 Rituxan_CMP_NonOnc.8.17.20-pdf.jpg
8/14/2025 1:56 PM 343148 Rituxan_CMP_NonOnc.8.17.20.pdf
8/14/2025 1:56 PM 7686 Rituxan_CMP_NonOnc.9.3.20-pdf-116x150.jpg
8/14/2025 1:56 PM 20244 Rituxan_CMP_NonOnc.9.3.20-pdf-232x300.jpg
8/14/2025 1:56 PM 144141 Rituxan_CMP_NonOnc.9.3.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 218762 Rituxan_CMP_NonOnc.9.3.20-pdf.jpg
8/14/2025 1:56 PM 342984 Rituxan_CMP_NonOnc.9.3.20.pdf
8/14/2025 1:56 PM 7853 short-acting_CSF_Nivestym_Neupogen_Granix_8.3.20-pdf-116x150.jpg
8/14/2025 1:56 PM 21153 short-acting_CSF_Nivestym_Neupogen_Granix_8.3.20-pdf-232x300.jpg
8/14/2025 1:56 PM 162390 short-acting_CSF_Nivestym_Neupogen_Granix_8.3.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 237102 short-acting_CSF_Nivestym_Neupogen_Granix_8.3.20-pdf.jpg
8/14/2025 1:56 PM 351538 short-acting_CSF_Nivestym_Neupogen_Granix_8.3.20.pdf
8/14/2025 1:56 PM 3390590 Spanish-Social-Media-Images.zip
8/14/2025 1:56 PM 4641 ST_Diclofenac-gel-1-pdf-116x150.jpg
8/14/2025 1:56 PM 8677 ST_Diclofenac-gel-1-pdf-232x300.jpg
8/14/2025 1:56 PM 46027 ST_Diclofenac-gel-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 68304 ST_Diclofenac-gel-1-pdf.jpg
8/14/2025 1:56 PM 81925 ST_Diclofenac-gel-1.pdf
8/14/2025 1:56 PM 25106 Stereotactic-Radiation-Therapy-UM-XRT_2006-pdf-116x150.jpg
8/14/2025 1:56 PM 42358 Stereotactic-Radiation-Therapy-UM-XRT_2006-pdf-232x300.jpg
8/14/2025 1:56 PM 243244 Stereotactic-Radiation-Therapy-UM-XRT_2006-pdf-791x1024.jpg
8/14/2025 1:56 PM 360068 Stereotactic-Radiation-Therapy-UM-XRT_2006-pdf.jpg
8/14/2025 1:56 PM 365301 Stereotactic-Radiation-Therapy-UM-XRT_2006.pdf
8/14/2025 1:56 PM 4144 Taltz-2013-A-SGM-P2020a-pdf-116x150.jpg
8/14/2025 1:56 PM 5848 Taltz-2013-A-SGM-P2020a-pdf-232x300.jpg
8/14/2025 1:56 PM 16818 Taltz-2013-A-SGM-P2020a-pdf-791x1024.jpg
8/14/2025 1:56 PM 21709 Taltz-2013-A-SGM-P2020a-pdf.jpg
8/14/2025 1:56 PM 152936 Taltz-2013-A-SGM-P2020a.pdf
8/14/2025 1:56 PM 15829 Template-Email-1_Portuguese.docx
8/14/2025 1:56 PM 14379 Template-Email.docx
8/14/2025 1:56 PM 15829 Template-Email_Portuguese.docx
8/14/2025 1:56 PM 15211 Template-Email_Spanish.docx
8/14/2025 1:56 PM 4894 Temporary-COVID-19-Testing-Treatment-Services-Payment-Policy-08.17.20-pdf-116x150.jpg
8/14/2025 1:56 PM 8256 Temporary-COVID-19-Testing-Treatment-Services-Payment-Policy-08.17.20-pdf-232x300.jpg
8/14/2025 1:56 PM 37569 Temporary-COVID-19-Testing-Treatment-Services-Payment-Policy-08.17.20-pdf-791x1024.jpg
8/14/2025 1:56 PM 48911 Temporary-COVID-19-Testing-Treatment-Services-Payment-Policy-08.17.20-pdf.jpg
8/14/2025 1:56 PM 641864 Temporary-COVID-19-Testing-Treatment-Services-Payment-Policy-08.17.20.pdf
8/14/2025 1:56 PM 9907 UM-ONC_1028-Avastin-bevacizumab-and-Biosimilars_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 25874 UM-ONC_1028-Avastin-bevacizumab-and-Biosimilars_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 206998 UM-ONC_1028-Avastin-bevacizumab-and-Biosimilars_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 312673 UM-ONC_1028-Avastin-bevacizumab-and-Biosimilars_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 231943 UM-ONC_1028-Avastin-bevacizumab-and-Biosimilars_07312020_cobranded.pdf
8/14/2025 1:56 PM 25265 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 42002 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 227746 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 333009 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 310807 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-2.pdf
8/18/2020 8:37 PM 25265 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 42002 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 227746 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 333009 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 310807 UM-ONC_1035-5HT3-Receptor-Antagonists_07312020_cobranded.pdf
8/14/2025 1:56 PM 4748 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-1-pdf-116x150.jpg
8/14/2025 1:56 PM 7136 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26824 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 36262 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-1-pdf.jpg
8/14/2025 1:56 PM 228652 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-1.pdf
8/14/2025 1:56 PM 4748 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-2-pdf-116x150.jpg
8/14/2025 1:56 PM 7136 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-2-pdf-232x300.jpg
8/14/2025 1:56 PM 26824 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 36262 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-2-pdf.jpg
8/14/2025 1:56 PM 228652 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-2.pdf
8/14/2025 1:56 PM 4748 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 7136 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26824 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36262 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020-pdf.jpg
8/14/2025 1:56 PM 228652 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020.pdf
8/14/2025 1:56 PM 21034 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 23700 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 45123 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 55099 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 307550 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-1.pdf
8/14/2025 1:56 PM 21034 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 23700 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 45123 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 55099 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 307550 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-2.pdf
8/18/2020 8:37 PM 21034 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 23700 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 45123 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 55099 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 307550 UM-ONC_1038-Emend-Cinvanti-and-Varubi_03012020_cobranded.pdf
8/14/2025 1:56 PM 20935 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 23241 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 42325 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 49477 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 312953 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-1.pdf
8/14/2025 1:56 PM 20935 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 23241 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 42325 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 49477 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 312953 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-2.pdf
8/18/2020 8:37 PM 20935 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 23241 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 42325 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 49477 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 312953 UM-ONC_1039-Faslodex-fulvestrant_04242020_cobranded.pdf
8/14/2025 1:56 PM 5186 UM-ONC_1041-LHRH-Agonists-and-antagonist_10302020-pdf-116x150.jpg
8/14/2025 1:56 PM 8923 UM-ONC_1041-LHRH-Agonists-and-antagonist_10302020-pdf-232x300.jpg
8/14/2025 1:56 PM 42773 UM-ONC_1041-LHRH-Agonists-and-antagonist_10302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 58948 UM-ONC_1041-LHRH-Agonists-and-antagonist_10302020-pdf.jpg
8/14/2025 1:56 PM 154378 UM-ONC_1041-LHRH-Agonists-and-antagonist_10302020.pdf
8/14/2025 1:56 PM 5177 UM-ONC_1041-LHRH-Agonists-and-antagonist_11302020-pdf-116x150.jpg
8/14/2025 1:56 PM 8939 UM-ONC_1041-LHRH-Agonists-and-antagonist_11302020-pdf-232x300.jpg
8/14/2025 1:56 PM 42729 UM-ONC_1041-LHRH-Agonists-and-antagonist_11302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 57983 UM-ONC_1041-LHRH-Agonists-and-antagonist_11302020-pdf.jpg
8/14/2025 1:56 PM 155690 UM-ONC_1041-LHRH-Agonists-and-antagonist_11302020.pdf
8/14/2025 1:56 PM 25235 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41950 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 231695 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 339193 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 332328 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-1.pdf
8/14/2025 1:56 PM 25235 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 41950 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 231695 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 339193 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 332328 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-2.pdf
8/18/2020 8:37 PM 25235 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 41950 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 231695 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 339193 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded-pdf.jpg
8/18/2020 8:37 PM 332328 UM-ONC_1041-LHRH-Agonists-and-antagonist_12112019_cobranded.pdf
8/14/2025 1:56 PM 6078 UM-ONC_1041-LHRH-Agonists-and-antagonist_12282020-pdf-116x150.jpg
8/14/2025 1:56 PM 9917 UM-ONC_1041-LHRH-Agonists-and-antagonist_12282020-pdf-232x300.jpg
8/14/2025 1:56 PM 40857 UM-ONC_1041-LHRH-Agonists-and-antagonist_12282020-pdf-791x1024.jpg
8/14/2025 1:56 PM 55776 UM-ONC_1041-LHRH-Agonists-and-antagonist_12282020-pdf.jpg
8/14/2025 1:56 PM 142891 UM-ONC_1041-LHRH-Agonists-and-antagonist_12282020.pdf
8/14/2025 1:56 PM 5625 UM-ONC_1042-Somatostatin-Analog-_03012020-1-pdf-116x150.jpg
8/14/2025 1:56 PM 8039 UM-ONC_1042-Somatostatin-Analog-_03012020-1-pdf-232x300.jpg
8/14/2025 1:56 PM 28015 UM-ONC_1042-Somatostatin-Analog-_03012020-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 36857 UM-ONC_1042-Somatostatin-Analog-_03012020-1-pdf.jpg
8/14/2025 1:56 PM 211099 UM-ONC_1042-Somatostatin-Analog-_03012020-1.pdf
8/14/2025 1:56 PM 5625 UM-ONC_1042-Somatostatin-Analog-_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 8039 UM-ONC_1042-Somatostatin-Analog-_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 28015 UM-ONC_1042-Somatostatin-Analog-_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36857 UM-ONC_1042-Somatostatin-Analog-_03012020-pdf.jpg
8/14/2025 1:56 PM 211099 UM-ONC_1042-Somatostatin-Analog-_03012020.pdf
8/14/2025 1:56 PM 21046 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 23739 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 44809 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 54707 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 312956 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-1.pdf
8/14/2025 1:56 PM 21046 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 23739 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 44809 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 54707 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 312956 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-2.pdf
8/18/2020 8:37 PM 21046 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 23739 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 44809 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 54707 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 312956 UM-ONC_1042-Somatostatin-Analog-_03012020_cobranded.pdf
8/14/2025 1:56 PM 24917 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40317 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 215681 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 311340 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 305064 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-1.pdf
8/18/2020 8:37 PM 24917 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 40317 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 215681 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 311340 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 305064 UM-ONC_1043-Tarceva-erlotinib_07312020_cobranded.pdf
8/14/2025 1:56 PM 25095 UM-ONC_1063-Oncospar-pegaspargase_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40814 UM-ONC_1063-Oncospar-pegaspargase_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 220039 UM-ONC_1063-Oncospar-pegaspargase_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 317764 UM-ONC_1063-Oncospar-pegaspargase_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 304192 UM-ONC_1063-Oncospar-pegaspargase_06262020_cobranded.pdf
8/14/2025 1:56 PM 25017 UM-ONC_1067-Proleukin-aldesleukin_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40165 UM-ONC_1067-Proleukin-aldesleukin_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 209857 UM-ONC_1067-Proleukin-aldesleukin_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 304854 UM-ONC_1067-Proleukin-aldesleukin_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 314831 UM-ONC_1067-Proleukin-aldesleukin_12112019_cobranded.pdf
8/14/2025 1:56 PM 4552 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020-pdf-116x150.jpg
8/14/2025 1:56 PM 6711 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020-pdf-232x300.jpg
8/14/2025 1:56 PM 24100 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020-pdf-791x1024.jpg
8/14/2025 1:56 PM 31918 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020-pdf.jpg
8/14/2025 1:56 PM 220710 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020.pdf
8/14/2025 1:56 PM 24979 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40566 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 217909 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 320428 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 300010 UM-ONC_1069-Trisenox-arsenic-trioxide_07312020_cobranded.pdf
8/14/2025 1:56 PM 24958 UM-ONC_1070-Valstar-valrubicin_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40659 UM-ONC_1070-Valstar-valrubicin_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 215813 UM-ONC_1070-Valstar-valrubicin_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 316190 UM-ONC_1070-Valstar-valrubicin_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 323434 UM-ONC_1070-Valstar-valrubicin_07312020_cobranded.pdf
8/14/2025 1:56 PM 25402 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 42676 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 237139 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 357385 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 340003 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-2.pdf
8/18/2020 8:37 PM 25402 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 42676 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 237139 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 357385 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 340003 UM-ONC_1072-Myeloid-Growth-Factors_05292020_cobranded.pdf
8/14/2025 1:56 PM 302299 UM-ONC_1089-Libtayo-cemiplimab-rwlc_04242020_cobranded-.pdf
8/14/2025 1:56 PM 20861 UM-ONC_1089-Libtayo-cemiplimab-rwlc_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 23147 UM-ONC_1089-Libtayo-cemiplimab-rwlc_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 42354 UM-ONC_1089-Libtayo-cemiplimab-rwlc_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 51051 UM-ONC_1089-Libtayo-cemiplimab-rwlc_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25090 UM-ONC_1130-Alimta-pemetrexed_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41668 UM-ONC_1130-Alimta-pemetrexed_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 220946 UM-ONC_1130-Alimta-pemetrexed_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 327998 UM-ONC_1130-Alimta-pemetrexed_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 300992 UM-ONC_1130-Alimta-pemetrexed_06262020_cobranded.pdf
8/14/2025 1:56 PM 25146 UM-ONC_1132-Rituximab-Products_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40936 UM-ONC_1132-Rituximab-Products_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 221935 UM-ONC_1132-Rituximab-Products_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 323084 UM-ONC_1132-Rituximab-Products_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 324710 UM-ONC_1132-Rituximab-Products_04242020_cobranded.pdf
8/14/2025 1:56 PM 4582 UM-ONC_1133-Erbitux-cetuximab_05292020-pdf-116x150.jpg
8/14/2025 1:56 PM 6692 UM-ONC_1133-Erbitux-cetuximab_05292020-pdf-232x300.jpg
8/14/2025 1:56 PM 23370 UM-ONC_1133-Erbitux-cetuximab_05292020-pdf-791x1024.jpg
8/14/2025 1:56 PM 32040 UM-ONC_1133-Erbitux-cetuximab_05292020-pdf.jpg
8/14/2025 1:56 PM 243029 UM-ONC_1133-Erbitux-cetuximab_05292020.pdf
8/14/2025 1:56 PM 20839 UM-ONC_1133-Erbitux-cetuximab_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 23061 UM-ONC_1133-Erbitux-cetuximab_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 42131 UM-ONC_1133-Erbitux-cetuximab_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 49051 UM-ONC_1133-Erbitux-cetuximab_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 323664 UM-ONC_1133-Erbitux-cetuximab_05292020_cobranded.pdf
8/14/2025 1:56 PM 5188 UM-ONC_1133-Erbitux-cetuximab_11302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9377 UM-ONC_1133-Erbitux-cetuximab_11302020-pdf-232x300.jpg
8/14/2025 1:56 PM 41788 UM-ONC_1133-Erbitux-cetuximab_11302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 56148 UM-ONC_1133-Erbitux-cetuximab_11302020-pdf.jpg
8/14/2025 1:56 PM 187664 UM-ONC_1133-Erbitux-cetuximab_11302020.pdf
8/14/2025 1:56 PM 25295 UM-ONC_1134-Trastuzumab-Products_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 42359 UM-ONC_1134-Trastuzumab-Products_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 233357 UM-ONC_1134-Trastuzumab-Products_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 341944 UM-ONC_1134-Trastuzumab-Products_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 596552 UM-ONC_1134-Trastuzumab-Products_07312020_cobranded.pdf
8/14/2025 1:56 PM 308689 UM-ONC_1135-Vectibix-panitumumab_04242020_cobranded-.pdf
8/14/2025 1:56 PM 20862 UM-ONC_1135-Vectibix-panitumumab_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 23161 UM-ONC_1135-Vectibix-panitumumab_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 42068 UM-ONC_1135-Vectibix-panitumumab_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 50948 UM-ONC_1135-Vectibix-panitumumab_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25017 UM-ONC_1136-Velcade-bortezomib_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41658 UM-ONC_1136-Velcade-bortezomib_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 214992 UM-ONC_1136-Velcade-bortezomib_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 317861 UM-ONC_1136-Velcade-bortezomib_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 327604 UM-ONC_1136-Velcade-bortezomib_06262020_cobranded.pdf
8/14/2025 1:56 PM 24662 UM-ONC_1136-Velcade-bortezomib_09252020-pdf-116x150.jpg
8/14/2025 1:56 PM 37680 UM-ONC_1136-Velcade-bortezomib_09252020-pdf-232x300.jpg
8/14/2025 1:56 PM 177748 UM-ONC_1136-Velcade-bortezomib_09252020-pdf-791x1024.jpg
8/14/2025 1:56 PM 254943 UM-ONC_1136-Velcade-bortezomib_09252020-pdf.jpg
8/14/2025 1:56 PM 273050 UM-ONC_1136-Velcade-bortezomib_09252020.pdf
8/14/2025 1:56 PM 25082 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 41547 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 227364 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 338376 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 312196 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-2.pdf
8/18/2020 8:37 PM 25082 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 41547 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 227364 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 338376 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded-pdf.jpg
8/18/2020 8:37 PM 312196 UM-ONC_1138-Erythropoiesis-Stimulating-Agents_03272020_cobranded.pdf
8/14/2025 1:56 PM 25117 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41112 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 213053 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 313128 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 309162 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-1.pdf
8/18/2020 8:37 PM 25117 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 41112 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 213053 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 313128 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 309162 UM-ONC_1177-Gleevec-imatinib-mesylate_04242020_cobranded.pdf
8/14/2025 1:56 PM 25025 UM-ONC_1179-Abraxane-nab-paclitaxel_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41611 UM-ONC_1179-Abraxane-nab-paclitaxel_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 224832 UM-ONC_1179-Abraxane-nab-paclitaxel_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 327778 UM-ONC_1179-Abraxane-nab-paclitaxel_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 305212 UM-ONC_1179-Abraxane-nab-paclitaxel_06262020_cobranded.pdf
8/14/2025 1:56 PM 25142 UM-ONC_1180-Intravenous-Immune-Globulin-IG_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41754 UM-ONC_1180-Intravenous-Immune-Globulin-IG_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 225703 UM-ONC_1180-Intravenous-Immune-Globulin-IG_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 327844 UM-ONC_1180-Intravenous-Immune-Globulin-IG_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 305076 UM-ONC_1180-Intravenous-Immune-Globulin-IG_05292020_cobranded.pdf
8/14/2025 1:56 PM 25162 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 42150 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 232270 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 339821 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 318343 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-1.pdf
8/14/2025 1:56 PM 25162 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 42150 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 232270 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 339821 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 318343 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-2.pdf
8/18/2020 8:38 PM 25162 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42150 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 232270 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 339821 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 318343 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_04242020_cobranded.pdf
8/14/2025 1:56 PM 5458 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-1-pdf-116x150.jpg
8/14/2025 1:56 PM 9813 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-1-pdf-232x300.jpg
8/14/2025 1:56 PM 46904 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 64347 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-1-pdf.jpg
8/14/2025 1:56 PM 223185 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-1.pdf
8/14/2025 1:56 PM 5458 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-2-pdf-116x150.jpg
8/14/2025 1:56 PM 9813 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-2-pdf-232x300.jpg
8/14/2025 1:56 PM 46904 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 64347 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-2-pdf.jpg
8/14/2025 1:56 PM 223185 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-2.pdf
8/14/2025 1:56 PM 5458 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9813 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-pdf-232x300.jpg
8/14/2025 1:56 PM 46904 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 64347 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020-pdf.jpg
8/14/2025 1:56 PM 223185 UM-ONC_1190-Bone-Modifying-Agents-Aredia-Zometa-Xgeva-Prolia_10302020.pdf
8/14/2025 1:56 PM 4576 UM-ONC_1192-Afinitor-everolimus_01082020-pdf-116x150.jpg
8/14/2025 1:56 PM 6647 UM-ONC_1192-Afinitor-everolimus_01082020-pdf-232x300.jpg
8/14/2025 1:56 PM 24402 UM-ONC_1192-Afinitor-everolimus_01082020-pdf-791x1024.jpg
8/14/2025 1:56 PM 32689 UM-ONC_1192-Afinitor-everolimus_01082020-pdf.jpg
8/14/2025 1:56 PM 230381 UM-ONC_1192-Afinitor-everolimus_01082020.pdf
8/14/2025 1:56 PM 25121 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40839 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 212231 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 308963 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 312266 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-1.pdf
8/18/2020 8:38 PM 25121 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40839 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 212231 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 308963 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded-pdf.jpg
8/18/2020 8:38 PM 312266 UM-ONC_1192-Afinitor-everolimus_01082020_cobranded.pdf
8/14/2025 1:56 PM 209934 UM-ONC_1192-Afinitor-everolimus_11302020-.pdf
8/14/2025 1:56 PM 5180 UM-ONC_1192-Afinitor-everolimus_11302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9383 UM-ONC_1192-Afinitor-everolimus_11302020-pdf-232x300.jpg
8/14/2025 1:56 PM 41723 UM-ONC_1192-Afinitor-everolimus_11302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 56455 UM-ONC_1192-Afinitor-everolimus_11302020-pdf.jpg
8/14/2025 1:56 PM 4535 UM-ONC_1193-Revlimid-lenalidomide_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 6785 UM-ONC_1193-Revlimid-lenalidomide_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26240 UM-ONC_1193-Revlimid-lenalidomide_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35497 UM-ONC_1193-Revlimid-lenalidomide_03272020-pdf.jpg
8/14/2025 1:56 PM 210536 UM-ONC_1193-Revlimid-lenalidomide_03272020.pdf
8/14/2025 1:56 PM 24960 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40026 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 214030 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 310343 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 292157 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-1.pdf
8/18/2020 8:38 PM 24960 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40026 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 214030 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 310343 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 292157 UM-ONC_1193-Revlimid-lenalidomide_03272020_cobranded.pdf
8/14/2025 1:56 PM 25016 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40946 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 219958 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 320524 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 303297 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-1.pdf
8/18/2020 8:38 PM 25016 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40946 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 219958 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 320524 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 303297 UM-ONC_1194-Nexavar-sorafenib_05292020_cobranded.pdf
8/14/2025 1:56 PM 25067 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40814 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 217845 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 319031 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 310306 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-1.pdf
8/18/2020 8:38 PM 25067 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40814 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 217845 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 319031 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 310306 UM-ONC_1195-Votrient-Pazopanib_06262020_cobranded.pdf
8/14/2025 1:56 PM 25170 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 42172 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 229674 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 342137 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 307043 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-1.pdf
8/18/2020 8:38 PM 25170 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42172 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 229674 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 342137 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 307043 UM-ONC_1196-Sprycel-dasatinib_06262020_cobranded.pdf
8/14/2025 1:56 PM 20718 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 23180 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 42597 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 50647 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 309203 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-1.pdf
8/18/2020 8:38 PM 20718 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 23180 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 42597 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 50647 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 309203 UM-ONC_1197-Sutent-sunitnib_05292020_cobranded.pdf
8/14/2025 1:56 PM 25246 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41667 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 226551 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 331073 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 305504 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-1.pdf
8/18/2020 8:38 PM 25246 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41667 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 226551 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 331073 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 305504 UM-ONC_1199-Tasigna-nilotinib_07312020_cobranded.pdf
8/14/2025 1:56 PM 25110 UM-ONC_1200-Torisel-temsirolimus_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40963 UM-ONC_1200-Torisel-temsirolimus_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 221662 UM-ONC_1200-Torisel-temsirolimus_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 323111 UM-ONC_1200-Torisel-temsirolimus_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 298880 UM-ONC_1200-Torisel-temsirolimus_06262020_cobranded.pdf
8/14/2025 1:56 PM 4587 UM-ONC_1201-Yervoy-ipilimumab_06262020-pdf-116x150.jpg
8/14/2025 1:56 PM 6691 UM-ONC_1201-Yervoy-ipilimumab_06262020-pdf-232x300.jpg
8/14/2025 1:56 PM 23843 UM-ONC_1201-Yervoy-ipilimumab_06262020-pdf-791x1024.jpg
8/14/2025 1:56 PM 31906 UM-ONC_1201-Yervoy-ipilimumab_06262020-pdf.jpg
8/14/2025 1:56 PM 236586 UM-ONC_1201-Yervoy-ipilimumab_06262020.pdf
8/14/2025 1:56 PM 25100 UM-ONC_1201-Yervoy-ipilimumab_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41291 UM-ONC_1201-Yervoy-ipilimumab_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 221155 UM-ONC_1201-Yervoy-ipilimumab_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 319370 UM-ONC_1201-Yervoy-ipilimumab_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 318636 UM-ONC_1201-Yervoy-ipilimumab_06262020_cobranded.pdf
8/14/2025 1:56 PM 4566 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020-pdf-116x150.jpg
8/14/2025 1:56 PM 6679 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020-pdf-232x300.jpg
8/14/2025 1:56 PM 23775 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020-pdf-791x1024.jpg
8/14/2025 1:56 PM 31875 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020-pdf.jpg
8/14/2025 1:56 PM 230240 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020.pdf
8/14/2025 1:56 PM 25084 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41331 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 225606 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 327216 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 313513 UM-ONC_1203-Adcetris-brentuximab-vedotin_04242020_cobranded.pdf
8/14/2025 1:56 PM 24998 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40987 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 213046 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 309428 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 315783 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-1.pdf
8/18/2020 8:38 PM 24998 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40987 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 213046 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 309428 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 315783 UM-ONC_1204-Caprelsa-vandetanib_07312020_cobranded.pdf
8/14/2025 1:56 PM 4620 UM-ONC_1205-Halaven-eribulin_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6760 UM-ONC_1205-Halaven-eribulin_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26267 UM-ONC_1205-Halaven-eribulin_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 34472 UM-ONC_1205-Halaven-eribulin_03012020-pdf.jpg
8/14/2025 1:56 PM 220130 UM-ONC_1205-Halaven-eribulin_03012020.pdf
8/14/2025 1:56 PM 25075 UM-ONC_1205-Halaven-eribulin_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40827 UM-ONC_1205-Halaven-eribulin_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 210985 UM-ONC_1205-Halaven-eribulin_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 317864 UM-ONC_1205-Halaven-eribulin_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 302416 UM-ONC_1205-Halaven-eribulin_03012020_cobranded.pdf
8/14/2025 1:56 PM 225751 UM-ONC_1206-Xalkori-crizotinib_03012020-.pdf
8/14/2025 1:56 PM 4655 UM-ONC_1206-Xalkori-crizotinib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6877 UM-ONC_1206-Xalkori-crizotinib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26588 UM-ONC_1206-Xalkori-crizotinib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35379 UM-ONC_1206-Xalkori-crizotinib_03012020-pdf.jpg
8/18/2020 8:38 PM 309587 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-.pdf
8/14/2025 1:56 PM 25192 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41304 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 219489 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 319066 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 309587 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-1-1.pdf
8/18/2020 8:38 PM 25192 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41304 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 219489 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 319066 UM-ONC_1206-Xalkori-crizotinib_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25148 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40983 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 221509 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 323981 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 304084 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-1.pdf
8/18/2020 8:38 PM 25148 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40983 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 221509 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 323981 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 304084 UM-ONC_1207-Zelboraf-vemurafenib_06262020_cobranded.pdf
8/14/2025 1:56 PM 25091 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41006 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 224672 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 325859 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 302790 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-1.pdf
8/18/2020 8:38 PM 25091 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41006 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 224672 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 325859 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 302790 UM-ONC_1208-Zytiga-or-Yonsa-abiraterone-acetate_04242020_cobranded.pdf
8/18/2020 8:38 PM 309037 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-.pdf
8/14/2025 1:56 PM 25084 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41481 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 230062 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 341191 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 309037 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-1-1.pdf
8/18/2020 8:38 PM 25084 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41481 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 230062 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 341191 UM-ONC_1213-Neumega-oprelvekin_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 24820 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 40390 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 220268 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 327656 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 333074 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-2.pdf
8/18/2020 8:38 PM 24820 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40390 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 220268 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 327656 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 333074 UM-ONC_1214-Intron-A-interferon-alfa-2b_12112019_cobranded.pdf
8/14/2025 1:56 PM 4576 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020-pdf-116x150.jpg
8/14/2025 1:56 PM 6702 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020-pdf-232x300.jpg
8/14/2025 1:56 PM 24132 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020-pdf-791x1024.jpg
8/14/2025 1:56 PM 32042 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020-pdf.jpg
8/14/2025 1:56 PM 222399 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020.pdf
8/14/2025 1:56 PM 24892 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40141 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 213601 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 307639 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 302687 UM-ONC_1215-Treanda_Bendeka_Belrapz-bendamustine_04242020_cobranded.pdf
8/14/2025 1:56 PM 25021 UM-ONC_1216-Perjeta-pertuzumab_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41240 UM-ONC_1216-Perjeta-pertuzumab_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 217153 UM-ONC_1216-Perjeta-pertuzumab_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 313190 UM-ONC_1216-Perjeta-pertuzumab_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 563894 UM-ONC_1216-Perjeta-pertuzumab_07312020_cobranded.pdf
8/14/2025 1:56 PM 4384 UM-ONC_1218-Provenge-sipuleucel-T_04242020-pdf-116x150.jpg
8/14/2025 1:56 PM 6390 UM-ONC_1218-Provenge-sipuleucel-T_04242020-pdf-232x300.jpg
8/14/2025 1:56 PM 24010 UM-ONC_1218-Provenge-sipuleucel-T_04242020-pdf-791x1024.jpg
8/14/2025 1:56 PM 30799 UM-ONC_1218-Provenge-sipuleucel-T_04242020-pdf.jpg
8/14/2025 1:56 PM 220264 UM-ONC_1218-Provenge-sipuleucel-T_04242020.pdf
8/14/2025 1:56 PM 25011 UM-ONC_1218-Provenge-sipuleucel-T_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40614 UM-ONC_1218-Provenge-sipuleucel-T_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 215197 UM-ONC_1218-Provenge-sipuleucel-T_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 325466 UM-ONC_1218-Provenge-sipuleucel-T_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 302227 UM-ONC_1218-Provenge-sipuleucel-T_04242020_cobranded.pdf
8/14/2025 1:56 PM 5168 UM-ONC_1219-Jevtana-cabazitaxel_01292021-pdf-116x150.jpg
8/14/2025 1:56 PM 8857 UM-ONC_1219-Jevtana-cabazitaxel_01292021-pdf-232x300.jpg
8/14/2025 1:56 PM 42611 UM-ONC_1219-Jevtana-cabazitaxel_01292021-pdf-791x1024.jpg
8/14/2025 1:56 PM 59293 UM-ONC_1219-Jevtana-cabazitaxel_01292021-pdf.jpg
8/14/2025 1:56 PM 209172 UM-ONC_1219-Jevtana-cabazitaxel_01292021.pdf
8/14/2025 1:56 PM 4683 UM-ONC_1219-Jevtana-cabazitaxel_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 6992 UM-ONC_1219-Jevtana-cabazitaxel_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26393 UM-ONC_1219-Jevtana-cabazitaxel_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35395 UM-ONC_1219-Jevtana-cabazitaxel_03272020-pdf.jpg
8/14/2025 1:56 PM 199321 UM-ONC_1219-Jevtana-cabazitaxel_03272020.pdf
8/14/2025 1:56 PM 24972 UM-ONC_1219-Jevtana-cabazitaxel_03272020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40570 UM-ONC_1219-Jevtana-cabazitaxel_03272020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 213229 UM-ONC_1219-Jevtana-cabazitaxel_03272020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 310028 UM-ONC_1219-Jevtana-cabazitaxel_03272020_cobranded-pdf.jpg
8/14/2025 1:56 PM 278510 UM-ONC_1219-Jevtana-cabazitaxel_03272020_cobranded.pdf
8/14/2025 1:56 PM 224890 UM-ONC_1220-Arzerra-ofatumumab_03012020-.pdf
8/14/2025 1:56 PM 4739 UM-ONC_1220-Arzerra-ofatumumab_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 7048 UM-ONC_1220-Arzerra-ofatumumab_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26838 UM-ONC_1220-Arzerra-ofatumumab_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35790 UM-ONC_1220-Arzerra-ofatumumab_03012020-pdf.jpg
8/14/2025 1:56 PM 304081 UM-ONC_1220-Arzerra-ofatumumab_03012020_cobranded-.pdf
8/14/2025 1:56 PM 25042 UM-ONC_1220-Arzerra-ofatumumab_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41230 UM-ONC_1220-Arzerra-ofatumumab_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 218238 UM-ONC_1220-Arzerra-ofatumumab_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 316420 UM-ONC_1220-Arzerra-ofatumumab_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25186 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 42973 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 245404 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 362546 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 314161 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-1.pdf
8/18/2020 8:38 PM 25186 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42973 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 245404 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 362546 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 314161 UM-ONC_1221-Bosulif-bosutinib_12112019_cobranded.pdf
8/14/2025 1:56 PM 200162 UM-ONC_1222-Erivedge-vismodegib_03272020-.pdf
8/14/2025 1:56 PM 4730 UM-ONC_1222-Erivedge-vismodegib_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 7045 UM-ONC_1222-Erivedge-vismodegib_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26890 UM-ONC_1222-Erivedge-vismodegib_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35945 UM-ONC_1222-Erivedge-vismodegib_03272020-pdf.jpg
8/18/2020 8:38 PM 282092 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-.pdf
8/14/2025 1:56 PM 25142 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41676 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 214359 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 314469 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 282092 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-1-1.pdf
8/18/2020 8:38 PM 25142 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41676 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 214359 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 314469 UM-ONC_1222-Erivedge-vismodegib_03272020_cobranded-pdf.jpg
8/14/2025 1:56 PM 204005 UM-ONC_1223-Inlyta-axitinib_03272020-.pdf
8/14/2025 1:56 PM 4720 UM-ONC_1223-Inlyta-axitinib_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 6989 UM-ONC_1223-Inlyta-axitinib_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26714 UM-ONC_1223-Inlyta-axitinib_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36337 UM-ONC_1223-Inlyta-axitinib_03272020-pdf.jpg
8/18/2020 8:38 PM 285984 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-.pdf
8/14/2025 1:56 PM 25108 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41522 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 210205 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 311722 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 285984 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-1-1.pdf
8/18/2020 8:38 PM 25108 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41522 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 210205 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 311722 UM-ONC_1223-Inlyta-axitinib_03272020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25064 UM-ONC_1224-Kyprolis-carfilzomib_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40791 UM-ONC_1224-Kyprolis-carfilzomib_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 216682 UM-ONC_1224-Kyprolis-carfilzomib_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 321949 UM-ONC_1224-Kyprolis-carfilzomib_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 284385 UM-ONC_1224-Kyprolis-carfilzomib_04242020_cobranded.pdf
8/14/2025 1:56 PM 24972 UM-ONC_1225-Voraxaze-glucarpidase_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41570 UM-ONC_1225-Voraxaze-glucarpidase_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 206399 UM-ONC_1225-Voraxaze-glucarpidase_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 303680 UM-ONC_1225-Voraxaze-glucarpidase_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 302075 UM-ONC_1225-Voraxaze-glucarpidase_12112019_cobranded.pdf
8/14/2025 1:56 PM 25318 UM-ONC_1226-Zaltrap-ziv-aflibercept_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 42195 UM-ONC_1226-Zaltrap-ziv-aflibercept_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 227771 UM-ONC_1226-Zaltrap-ziv-aflibercept_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 332419 UM-ONC_1226-Zaltrap-ziv-aflibercept_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 298972 UM-ONC_1226-Zaltrap-ziv-aflibercept_06262020_cobranded.pdf
8/14/2025 1:56 PM 203470 UM-ONC_1227-Zolinza-vorinostat_03272020-.pdf
8/14/2025 1:56 PM 4719 UM-ONC_1227-Zolinza-vorinostat_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 7063 UM-ONC_1227-Zolinza-vorinostat_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26415 UM-ONC_1227-Zolinza-vorinostat_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35957 UM-ONC_1227-Zolinza-vorinostat_03272020-pdf.jpg
8/14/2025 1:56 PM 4709 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 7033 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26719 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35638 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 202280 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-1.pdf
8/18/2020 8:38 PM 4709 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 7033 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26719 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 35638 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 202280 UM-ONC_1227-Zolinza-vorinostat_03272020_cobranded.pdf
8/18/2020 8:38 PM 25138 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41553 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 217941 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 313183 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 326587 UM-ONC_1228-Xtandi-enzalutamide_07312020_cobranded.pdf
8/14/2025 1:56 PM 4675 UM-ONC_1230-Istodax-romidepsin_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 6929 UM-ONC_1230-Istodax-romidepsin_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26939 UM-ONC_1230-Istodax-romidepsin_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36068 UM-ONC_1230-Istodax-romidepsin_03272020-pdf.jpg
8/14/2025 1:56 PM 202946 UM-ONC_1230-Istodax-romidepsin_03272020.pdf
8/14/2025 1:56 PM 24982 UM-ONC_1230-Istodax-romidepsin_03272020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40230 UM-ONC_1230-Istodax-romidepsin_03272020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 207907 UM-ONC_1230-Istodax-romidepsin_03272020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 303177 UM-ONC_1230-Istodax-romidepsin_03272020_cobranded-pdf.jpg
8/14/2025 1:56 PM 282059 UM-ONC_1230-Istodax-romidepsin_03272020_cobranded.pdf
8/14/2025 1:56 PM 5295 UM-ONC_1231-Marqibo-vincristine-liposome_01292021-pdf-116x150.jpg
8/14/2025 1:56 PM 9330 UM-ONC_1231-Marqibo-vincristine-liposome_01292021-pdf-232x300.jpg
8/14/2025 1:56 PM 44732 UM-ONC_1231-Marqibo-vincristine-liposome_01292021-pdf-791x1024.jpg
8/14/2025 1:56 PM 62485 UM-ONC_1231-Marqibo-vincristine-liposome_01292021-pdf.jpg
8/14/2025 1:56 PM 209576 UM-ONC_1231-Marqibo-vincristine-liposome_01292021.pdf
8/14/2025 1:56 PM 200886 UM-ONC_1231-Marqibo-vincristine-liposome_03272020-.pdf
8/14/2025 1:56 PM 4683 UM-ONC_1231-Marqibo-vincristine-liposome_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 6849 UM-ONC_1231-Marqibo-vincristine-liposome_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26836 UM-ONC_1231-Marqibo-vincristine-liposome_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35739 UM-ONC_1231-Marqibo-vincristine-liposome_03272020-pdf.jpg
8/14/2025 1:56 PM 282848 UM-ONC_1231-Marqibo-vincristine-liposome_03272020_cobranded-.pdf
8/14/2025 1:56 PM 25038 UM-ONC_1231-Marqibo-vincristine-liposome_03272020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40886 UM-ONC_1231-Marqibo-vincristine-liposome_03272020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 216080 UM-ONC_1231-Marqibo-vincristine-liposome_03272020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 311114 UM-ONC_1231-Marqibo-vincristine-liposome_03272020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25096 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40667 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 218766 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 321714 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 299742 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-1.pdf
8/18/2020 8:38 PM 25096 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40667 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 218766 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 321714 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 299742 UM-ONC_1232-Stivarga-regorafenib_05292020_cobranded.pdf
8/14/2025 1:56 PM 5202 UM-ONC_1233-Tykerb-lapatinib_01292021-pdf-116x150.jpg
8/14/2025 1:56 PM 9011 UM-ONC_1233-Tykerb-lapatinib_01292021-pdf-232x300.jpg
8/14/2025 1:56 PM 40495 UM-ONC_1233-Tykerb-lapatinib_01292021-pdf-791x1024.jpg
8/14/2025 1:56 PM 57351 UM-ONC_1233-Tykerb-lapatinib_01292021-pdf.jpg
8/14/2025 1:56 PM 214175 UM-ONC_1233-Tykerb-lapatinib_01292021.pdf
8/14/2025 1:56 PM 4700 UM-ONC_1233-Tykerb-lapatinib_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 6976 UM-ONC_1233-Tykerb-lapatinib_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26446 UM-ONC_1233-Tykerb-lapatinib_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35644 UM-ONC_1233-Tykerb-lapatinib_03272020-pdf.jpg
8/14/2025 1:56 PM 200989 UM-ONC_1233-Tykerb-lapatinib_03272020.pdf
8/14/2025 1:56 PM 25020 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40800 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 208914 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 303890 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 278384 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-1.pdf
8/18/2020 8:38 PM 25020 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40800 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 208914 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 303890 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded-pdf.jpg
8/18/2020 8:38 PM 278384 UM-ONC_1233-Tykerb-lapatinib_03272020_cobranded.pdf
8/14/2025 1:56 PM 25003 UM-ONC_1235-Doxil-or-Lipodox-liposomal-doxorubicin_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40596 UM-ONC_1235-Doxil-or-Lipodox-liposomal-doxorubicin_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 214088 UM-ONC_1235-Doxil-or-Lipodox-liposomal-doxorubicin_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 311087 UM-ONC_1235-Doxil-or-Lipodox-liposomal-doxorubicin_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 304621 UM-ONC_1235-Doxil-or-Lipodox-liposomal-doxorubicin_04242020_cobranded.pdf
8/18/2020 8:38 PM 313114 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-.pdf
8/14/2025 1:56 PM 25073 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41516 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 213183 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 312590 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 313114 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-1-1.pdf
8/18/2020 8:38 PM 25073 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41516 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 213183 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 312590 UM-ONC_1237-Cometriq-or-Cabometyx-cabozantinib_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25142 UM-ONC_1238-Kadcyla-ado-trastuzumab-emtansine_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41351 UM-ONC_1238-Kadcyla-ado-trastuzumab-emtansine_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 228422 UM-ONC_1238-Kadcyla-ado-trastuzumab-emtansine_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 331648 UM-ONC_1238-Kadcyla-ado-trastuzumab-emtansine_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 557331 UM-ONC_1238-Kadcyla-ado-trastuzumab-emtansine_04242020_cobranded.pdf
8/14/2025 1:56 PM 4507 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6579 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23975 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31706 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 221458 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-1.pdf
8/18/2020 8:38 PM 4507 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6579 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23975 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31706 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 221458 UM-ONC_1239-Pomalyst-pomalidomide_07312020_cobranded.pdf
8/14/2025 1:56 PM 20838 UM-ONC_1240-Synribo-omacetaxine_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 23145 UM-ONC_1240-Synribo-omacetaxine_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 42009 UM-ONC_1240-Synribo-omacetaxine_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 50632 UM-ONC_1240-Synribo-omacetaxine_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 301681 UM-ONC_1240-Synribo-omacetaxine_06262020_cobranded.pdf
8/14/2025 1:56 PM 25214 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 42154 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 234371 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 341716 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 313523 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-1.pdf
8/18/2020 8:38 PM 25214 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 42154 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 234371 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 341716 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 313523 UM-ONC_1241-Iclusig-ponatinib_12112019_cobranded.pdf
8/14/2025 1:56 PM 25086 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40809 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 219409 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 318240 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 303410 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-1.pdf
8/18/2020 8:38 PM 25086 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40809 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 219409 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 318240 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 303410 UM-ONC_1242-Jakafi-ruxolitinib_04242020_cobranded.pdf
8/18/2020 8:38 PM 25052 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40715 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 205246 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 305380 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 325312 UM-ONC_1244-Promacta-eltrombopag_12112019_cobranded.pdf
8/14/2025 1:56 PM 220306 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020-.pdf
8/14/2025 1:56 PM 4675 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6901 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26178 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36002 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020-pdf.jpg
8/14/2025 1:56 PM 301255 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020_cobranded-.pdf
8/14/2025 1:56 PM 25018 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40090 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 212676 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 307493 UM-ONC_1245-Xofigo-radium-Ra-223-dichloride_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 219917 UM-ONC_1248-Ixempra-ixabepilone_03012020-.pdf
8/14/2025 1:56 PM 4643 UM-ONC_1248-Ixempra-ixabepilone_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6928 UM-ONC_1248-Ixempra-ixabepilone_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26288 UM-ONC_1248-Ixempra-ixabepilone_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35412 UM-ONC_1248-Ixempra-ixabepilone_03012020-pdf.jpg
8/14/2025 1:56 PM 298983 UM-ONC_1248-Ixempra-ixabepilone_03012020_cobranded-.pdf
8/14/2025 1:56 PM 24975 UM-ONC_1248-Ixempra-ixabepilone_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40199 UM-ONC_1248-Ixempra-ixabepilone_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 207179 UM-ONC_1248-Ixempra-ixabepilone_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 310192 UM-ONC_1248-Ixempra-ixabepilone_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 227122 UM-ONC_1249-Mekinist-trametinib_03012020-.pdf
8/14/2025 1:56 PM 4722 UM-ONC_1249-Mekinist-trametinib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 7037 UM-ONC_1249-Mekinist-trametinib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26253 UM-ONC_1249-Mekinist-trametinib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36018 UM-ONC_1249-Mekinist-trametinib_03012020-pdf.jpg
8/18/2020 8:38 PM 308791 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-.pdf
8/14/2025 1:56 PM 25001 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40905 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 213746 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 311527 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 308791 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-1-1.pdf
8/18/2020 8:38 PM 25001 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40905 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 213746 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 311527 UM-ONC_1249-Mekinist-trametinib_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25100 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41039 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 223997 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 324294 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 307811 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-1.pdf
8/18/2020 8:38 PM 25100 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41039 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 223997 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 324294 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 307811 UM-ONC_1250-Tafinlar-dabrafenib_06262020_cobranded.pdf
8/14/2025 1:56 PM 25135 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41130 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 218821 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 327646 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 283058 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-1.pdf
8/18/2020 8:38 PM 25135 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41130 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 218821 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 327646 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 283058 UM-ONC_1258-Gilotrif-afatanib_04242020_cobranded.pdf
8/14/2025 1:56 PM 20911 UM-ONC_1259-Gazyva-obinutuzumab_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 23319 UM-ONC_1259-Gazyva-obinutuzumab_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 42049 UM-ONC_1259-Gazyva-obinutuzumab_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 49357 UM-ONC_1259-Gazyva-obinutuzumab_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 304844 UM-ONC_1259-Gazyva-obinutuzumab_04242020_cobranded.pdf
8/14/2025 1:56 PM 25117 UM-ONC_1260-Beleodaq-belinosat_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41503 UM-ONC_1260-Beleodaq-belinosat_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 216925 UM-ONC_1260-Beleodaq-belinosat_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 314385 UM-ONC_1260-Beleodaq-belinosat_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 300477 UM-ONC_1260-Beleodaq-belinosat_04242020_cobranded.pdf
8/14/2025 1:56 PM 25073 UM-ONC_1261-Cyramza-ramucirumab_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40679 UM-ONC_1261-Cyramza-ramucirumab_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 220461 UM-ONC_1261-Cyramza-ramucirumab_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 321251 UM-ONC_1261-Cyramza-ramucirumab_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 304631 UM-ONC_1261-Cyramza-ramucirumab_07312020_cobranded.pdf
8/18/2020 8:38 PM 24992 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40097 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 212403 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 306433 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 309129 UM-ONC_1262-Imbruvica-ibrutinib_05292020_cobranded.pdf
8/14/2025 1:56 PM 25081 UM-ONC_1263-Keytruda-pembrolizumab_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 41400 UM-ONC_1263-Keytruda-pembrolizumab_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 216393 UM-ONC_1263-Keytruda-pembrolizumab_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 322382 UM-ONC_1263-Keytruda-pembrolizumab_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 326896 UM-ONC_1263-Keytruda-pembrolizumab_06262020_cobranded.pdf
8/14/2025 1:56 PM 20835 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 23190 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 42306 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 50968 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 305568 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-1.pdf
8/18/2020 8:38 PM 20835 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 23190 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 42306 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 50968 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded-pdf.jpg
8/18/2020 8:38 PM 305568 UM-ONC_1264-Zydelig-idelalisib_05292020_cobranded.pdf
8/14/2025 1:56 PM 222883 UM-ONC_1265-Zykadia-ceritinib_03012020-.pdf
8/14/2025 1:56 PM 4785 UM-ONC_1265-Zykadia-ceritinib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 7146 UM-ONC_1265-Zykadia-ceritinib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26371 UM-ONC_1265-Zykadia-ceritinib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36048 UM-ONC_1265-Zykadia-ceritinib_03012020-pdf.jpg
8/18/2020 8:38 PM 301639 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-.pdf
8/14/2025 1:56 PM 25045 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41308 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 212931 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 310421 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 301639 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-1-1.pdf
8/18/2020 8:38 PM 25045 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41308 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 212931 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 310421 UM-ONC_1265-Zykadia-ceritinib_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 25089 UM-ONC_1270-Blincyto-blinatumomab_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 40904 UM-ONC_1270-Blincyto-blinatumomab_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 210989 UM-ONC_1270-Blincyto-blinatumomab_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 306283 UM-ONC_1270-Blincyto-blinatumomab_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 301043 UM-ONC_1270-Blincyto-blinatumomab_04242020_cobranded.pdf
8/14/2025 1:56 PM 25180 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 41383 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 217214 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 318075 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 301275 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-1.pdf
8/18/2020 8:38 PM 25180 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 41383 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 217214 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 318075 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 301275 UM-ONC_1271-Farydak-panobinostat_06262020_cobranded.pdf
8/18/2020 8:38 PM 300118 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-.pdf
8/14/2025 1:56 PM 25062 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-1-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40926 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-1-1-pdf-232x300.jpg
8/14/2025 1:56 PM 211965 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-1-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 312167 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-1-1-pdf.jpg
8/14/2025 1:56 PM 300118 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-1-1.pdf
8/18/2020 8:38 PM 25062 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40926 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 211965 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 312167 UM-ONC_1272-Ibrance-palbociclib_03272020_cobranded-pdf.jpg
8/14/2025 1:56 PM 24802 UM-ONC_1272-Ibrance-palbociclib_09252020-pdf-116x150.jpg
8/14/2025 1:56 PM 38698 UM-ONC_1272-Ibrance-palbociclib_09252020-pdf-232x300.jpg
8/14/2025 1:56 PM 185580 UM-ONC_1272-Ibrance-palbociclib_09252020-pdf-791x1024.jpg
8/14/2025 1:56 PM 267575 UM-ONC_1272-Ibrance-palbociclib_09252020-pdf.jpg
8/14/2025 1:56 PM 321329 UM-ONC_1272-Ibrance-palbociclib_09252020.pdf
8/14/2025 1:56 PM 25114 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 40802 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 222328 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 322234 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 309150 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-1.pdf
8/18/2020 8:38 PM 25114 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 40802 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 222328 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 322234 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded-pdf.jpg
8/18/2020 8:38 PM 309150 UM-ONC_1273-Lynparza-olaparib_07312020_cobranded.pdf
8/14/2025 1:56 PM 5516 UM-ONC_1274-Opdivo-nivolumab_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 7570 UM-ONC_1274-Opdivo-nivolumab_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 25034 UM-ONC_1274-Opdivo-nivolumab_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32487 UM-ONC_1274-Opdivo-nivolumab_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 310829 UM-ONC_1274-Opdivo-nivolumab_07312020_cobranded.pdf
8/14/2025 1:56 PM 5192 UM-ONC_1274-Opdivo-nivolumab_10302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9342 UM-ONC_1274-Opdivo-nivolumab_10302020-pdf-232x300.jpg
8/14/2025 1:56 PM 41293 UM-ONC_1274-Opdivo-nivolumab_10302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 56387 UM-ONC_1274-Opdivo-nivolumab_10302020-pdf.jpg
8/14/2025 1:56 PM 299714 UM-ONC_1274-Opdivo-nivolumab_10302020.pdf
8/14/2025 1:56 PM 5183 UM-ONC_1274-Opdivo-nivolumab_11302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9435 UM-ONC_1274-Opdivo-nivolumab_11302020-pdf-232x300.jpg
8/14/2025 1:56 PM 41453 UM-ONC_1274-Opdivo-nivolumab_11302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 56655 UM-ONC_1274-Opdivo-nivolumab_11302020-pdf.jpg
8/14/2025 1:56 PM 302466 UM-ONC_1274-Opdivo-nivolumab_11302020.pdf
8/14/2025 1:56 PM 4404 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6479 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 24565 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 33694 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020-pdf.jpg
8/14/2025 1:56 PM 215555 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020.pdf
8/14/2025 1:56 PM 4451 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6528 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24562 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 33512 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 214426 UM-ONC_1276-Onivyde-irinotecan-liposome_03012020_cobranded.pdf
8/14/2025 1:56 PM 5444 UM-ONC_1276-Onivyde-irinotecan-liposome_11302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9657 UM-ONC_1276-Onivyde-irinotecan-liposome_11302020-pdf-232x300.jpg
8/14/2025 1:56 PM 44363 UM-ONC_1276-Onivyde-irinotecan-liposome_11302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 61111 UM-ONC_1276-Onivyde-irinotecan-liposome_11302020-pdf.jpg
8/14/2025 1:56 PM 184144 UM-ONC_1276-Onivyde-irinotecan-liposome_11302020.pdf
8/14/2025 1:56 PM 227691 UM-ONC_1277-Alecensa-Alectinib_03012020-.pdf
8/14/2025 1:56 PM 6586 UM-ONC_1277-Alecensa-Alectinib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 14391 UM-ONC_1277-Alecensa-Alectinib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 104959 UM-ONC_1277-Alecensa-Alectinib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 154231 UM-ONC_1277-Alecensa-Alectinib_03012020-pdf.jpg
8/14/2025 1:56 PM 6650 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 14261 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 104782 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 151591 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 226212 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-1.pdf
8/18/2020 8:38 PM 6650 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 14261 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 104782 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 151591 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 226212 UM-ONC_1277-Alecensa-Alectinib_03012020_cobranded.pdf
8/14/2025 1:56 PM 4607 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6799 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26327 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 34029 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 234786 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-1.pdf
8/18/2020 8:38 PM 4607 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6799 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26327 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 34029 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded-pdf.jpg
8/18/2020 8:38 PM 234786 UM-ONC_1279-Cotellic-cobimetinib_01082020_cobranded.pdf
8/14/2025 1:56 PM 4973 UM-ONC_1280-Darzalex-and-Darzalex-Faspro-daratumumab_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 7933 UM-ONC_1280-Darzalex-and-Darzalex-Faspro-daratumumab_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 30567 UM-ONC_1280-Darzalex-and-Darzalex-Faspro-daratumumab_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 42055 UM-ONC_1280-Darzalex-and-Darzalex-Faspro-daratumumab_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 223697 UM-ONC_1280-Darzalex-and-Darzalex-Faspro-daratumumab_06262020_cobranded.pdf
8/14/2025 1:56 PM 4565 UM-ONC_1281-Empliciti-elotuzumab_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6651 UM-ONC_1281-Empliciti-elotuzumab_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24047 UM-ONC_1281-Empliciti-elotuzumab_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31931 UM-ONC_1281-Empliciti-elotuzumab_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 216202 UM-ONC_1281-Empliciti-elotuzumab_05292020_cobranded.pdf
8/14/2025 1:56 PM 7474 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020-pdf-116x150.jpg
8/14/2025 1:56 PM 17101 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020-pdf-232x300.jpg
8/14/2025 1:56 PM 124617 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020-pdf-791x1024.jpg
8/14/2025 1:56 PM 183800 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020-pdf.jpg
8/14/2025 1:56 PM 235910 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020.pdf
8/14/2025 1:56 PM 7392 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 16234 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 118542 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 169416 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020_cobranded-pdf.jpg
8/14/2025 1:56 PM 238778 UM-ONC_1282-Imlygic-Talimogene-Laherparepvec_01082020_cobranded.pdf
8/14/2025 1:56 PM 4545 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6551 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24173 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 30322 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 226929 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-1.pdf
8/18/2020 8:38 PM 4545 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6551 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 24173 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 30322 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 226929 UM-ONC_1283-Lenvima-lenvatinib_04242020_cobranded.pdf
8/14/2025 1:56 PM 211689 UM-ONC_1284-Ninlaro-ixazomib_01082020-.pdf
8/14/2025 1:56 PM 5787 UM-ONC_1284-Ninlaro-ixazomib_01082020-pdf-116x150.jpg
8/14/2025 1:56 PM 9928 UM-ONC_1284-Ninlaro-ixazomib_01082020-pdf-232x300.jpg
8/14/2025 1:56 PM 54768 UM-ONC_1284-Ninlaro-ixazomib_01082020-pdf-791x1024.jpg
8/14/2025 1:56 PM 79866 UM-ONC_1284-Ninlaro-ixazomib_01082020-pdf.jpg
8/14/2025 1:56 PM 5868 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 10025 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 56368 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 79530 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 233855 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-1.pdf
8/18/2020 8:38 PM 5868 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 10025 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 56368 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 79530 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded-pdf.jpg
8/18/2020 8:38 PM 233855 UM-ONC_1284-Ninlaro-ixazomib_01082020_cobranded.pdf
8/14/2025 1:56 PM 4627 UM-ONC_1287-Tagrisso-osimertinib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 7088 UM-ONC_1287-Tagrisso-osimertinib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26793 UM-ONC_1287-Tagrisso-osimertinib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35386 UM-ONC_1287-Tagrisso-osimertinib_03012020-pdf.jpg
8/14/2025 1:56 PM 224432 UM-ONC_1287-Tagrisso-osimertinib_03012020.pdf
8/14/2025 1:56 PM 4653 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6958 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26036 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35330 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 223116 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-1.pdf
8/18/2020 8:38 PM 4653 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6958 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26036 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 35330 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 223116 UM-ONC_1287-Tagrisso-osimertinib_03012020_cobranded.pdf
8/14/2025 1:56 PM 225885 UM-ONC_1288-Fusilev-levoleucovorin_03012020-.pdf
8/14/2025 1:56 PM 4738 UM-ONC_1288-Fusilev-levoleucovorin_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6960 UM-ONC_1288-Fusilev-levoleucovorin_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26497 UM-ONC_1288-Fusilev-levoleucovorin_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36207 UM-ONC_1288-Fusilev-levoleucovorin_03012020-pdf.jpg
8/14/2025 1:56 PM 4668 UM-ONC_1288-Fusilev-levoleucovorin_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6777 UM-ONC_1288-Fusilev-levoleucovorin_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 26348 UM-ONC_1288-Fusilev-levoleucovorin_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 34296 UM-ONC_1288-Fusilev-levoleucovorin_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 224595 UM-ONC_1288-Fusilev-levoleucovorin_03012020_cobranded.pdf
8/14/2025 1:56 PM 5478 UM-ONC_1288-Fusilev-levoleucovorin_11302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9900 UM-ONC_1288-Fusilev-levoleucovorin_11302020-pdf-232x300.jpg
8/14/2025 1:56 PM 45661 UM-ONC_1288-Fusilev-levoleucovorin_11302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 63467 UM-ONC_1288-Fusilev-levoleucovorin_11302020-pdf.jpg
8/14/2025 1:56 PM 214687 UM-ONC_1288-Fusilev-levoleucovorin_11302020.pdf
8/18/2020 8:38 PM 4694 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6891 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 26580 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 35594 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded-pdf.jpg
8/18/2020 8:38 PM 220289 UM-ONC_1289-Vistogard-uridine-triacetate_03012020_cobranded.pdf
8/14/2025 1:56 PM 221142 UM-ONC_1290-Yondelis-trabectedin_03012020-.pdf
8/14/2025 1:56 PM 4695 UM-ONC_1290-Yondelis-trabectedin_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6890 UM-ONC_1290-Yondelis-trabectedin_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26539 UM-ONC_1290-Yondelis-trabectedin_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36273 UM-ONC_1290-Yondelis-trabectedin_03012020-pdf.jpg
8/14/2025 1:56 PM 4690 UM-ONC_1290-Yondelis-trabectedin_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6922 UM-ONC_1290-Yondelis-trabectedin_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 26503 UM-ONC_1290-Yondelis-trabectedin_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 33864 UM-ONC_1290-Yondelis-trabectedin_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 219833 UM-ONC_1290-Yondelis-trabectedin_03012020_cobranded.pdf
8/14/2025 1:56 PM 4511 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6610 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23842 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31295 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 223641 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-1.pdf
8/18/2020 8:38 PM 4511 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6610 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23842 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31295 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 223641 UM-ONC_1297-Venclexa-venetoclax_06262020_cobranded.pdf
8/14/2025 1:56 PM 4540 UM-ONC_1299-Tecentriq-atezolizumab_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6657 UM-ONC_1299-Tecentriq-atezolizumab_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23637 UM-ONC_1299-Tecentriq-atezolizumab_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31175 UM-ONC_1299-Tecentriq-atezolizumab_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 230525 UM-ONC_1299-Tecentriq-atezolizumab_07312020_cobranded.pdf
8/14/2025 1:56 PM 4540 UM-ONC_1300-Lartruvo-olaratumab_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6666 UM-ONC_1300-Lartruvo-olaratumab_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24363 UM-ONC_1300-Lartruvo-olaratumab_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31939 UM-ONC_1300-Lartruvo-olaratumab_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 223166 UM-ONC_1300-Lartruvo-olaratumab_12112019_cobranded.pdf
8/14/2025 1:56 PM 4409 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6312 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 22606 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 30517 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 208614 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-1.pdf
8/18/2020 8:38 PM 4409 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6312 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 22606 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 30517 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded-pdf.jpg
8/18/2020 8:38 PM 208614 UM-ONC_1301-Rubraca-rucaparib_06262020_cobranded.pdf
8/14/2025 1:56 PM 4540 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6657 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23637 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31175 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 220380 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-1.pdf
8/18/2020 8:38 PM 4540 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6657 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23637 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31175 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded-pdf.jpg
8/18/2020 8:38 PM 220380 UM-ONC_1303-Xermelo-telotristat-ethyl_12112019_cobranded.pdf
8/14/2025 1:56 PM 4431 UM-ONC_1306-Bavencio-avelumab_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6283 UM-ONC_1306-Bavencio-avelumab_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23312 UM-ONC_1306-Bavencio-avelumab_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 30561 UM-ONC_1306-Bavencio-avelumab_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 221595 UM-ONC_1306-Bavencio-avelumab_04242020_cobranded.pdf
8/14/2025 1:56 PM 4561 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6753 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23640 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31690 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-1-pdf.jpg
8/14/2025 1:56 PM 223034 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-1.pdf
8/18/2020 8:38 PM 4561 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6753 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23640 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31690 UM-ONC_1307-Zejula-niraparib_06262020-cobranded-pdf.jpg
8/18/2020 8:38 PM 223034 UM-ONC_1307-Zejula-niraparib_06262020-cobranded.pdf
8/14/2025 1:56 PM 4416 UM-ONC_1308-Folotyn-pralatrexate_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6192 UM-ONC_1308-Folotyn-pralatrexate_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23093 UM-ONC_1308-Folotyn-pralatrexate_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31423 UM-ONC_1308-Folotyn-pralatrexate_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 225003 UM-ONC_1308-Folotyn-pralatrexate_04242020_cobranded.pdf
8/14/2025 1:56 PM 4551 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6663 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24258 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31955 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 207085 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-1.pdf
8/18/2020 8:38 PM 4551 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6663 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 24258 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31955 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 207085 UM-ONC_1309-Iressa-gefitinib_04242020_cobranded.pdf
8/14/2025 1:56 PM 4576 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6674 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23979 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31949 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 205699 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-1.pdf
8/18/2020 8:38 PM 4576 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:38 PM 6674 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:38 PM 23979 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:38 PM 31949 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 205699 UM-ONC_1310-Kisqali-ribociclib_04242020_cobranded.pdf
8/14/2025 1:56 PM 4527 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6569 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23984 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 30627 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 200540 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-1.pdf
8/18/2020 8:39 PM 4527 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6569 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23984 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 30627 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded-pdf.jpg
8/18/2020 8:38 PM 200540 UM-ONC_1311-Lonsurf-trifluridine_tipiracil_04242020_cobranded.pdf
8/14/2025 1:56 PM 4444 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6348 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23793 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31493 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 216622 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-1.pdf
8/18/2020 8:39 PM 4444 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6348 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23793 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31493 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded-pdf.jpg
8/18/2020 8:39 PM 216622 UM-ONC_1312-Odomzo-sonidegib_04242020_cobranded.pdf
8/14/2025 1:56 PM 4568 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6606 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24929 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31942 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 227778 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-1.pdf
8/18/2020 8:39 PM 4568 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6606 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24929 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31942 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 227778 UM-ONC_1313-Alunbrig-brigatinib_07312020_cobranded.pdf
8/14/2025 1:56 PM 4525 UM-ONC_1314-Imfinzi-durvalumab_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6612 UM-ONC_1314-Imfinzi-durvalumab_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24100 UM-ONC_1314-Imfinzi-durvalumab_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32027 UM-ONC_1314-Imfinzi-durvalumab_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 223782 UM-ONC_1314-Imfinzi-durvalumab_05292020_cobranded.pdf
8/14/2025 1:56 PM 4502 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6530 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23823 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31848 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 219451 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-1.pdf
8/18/2020 8:39 PM 4502 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6530 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23823 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31848 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 219451 UM-ONC_1315-Rydapt-midostaurin_07312020_cobranded.pdf
8/14/2025 1:56 PM 4516 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6581 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24173 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 32272 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 217274 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-1.pdf
8/18/2020 8:39 PM 4516 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6581 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24173 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32272 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded-pdf.jpg
8/18/2020 8:39 PM 217274 UM-ONC_1316-Nerlynx-neratinib_04242020_cobranded.pdf
8/18/2020 8:39 PM 4569 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6623 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24348 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32190 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 225256 UM-ONC_1323-Idhifa-enasidenib_12112019_cobranded.pdf
8/14/2025 1:56 PM 4580 UM-ONC_1324-Kymriah-tisagenlecleucel_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6673 UM-ONC_1324-Kymriah-tisagenlecleucel_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23928 UM-ONC_1324-Kymriah-tisagenlecleucel_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31999 UM-ONC_1324-Kymriah-tisagenlecleucel_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 222671 UM-ONC_1324-Kymriah-tisagenlecleucel_06262020_cobranded.pdf
8/14/2025 1:56 PM 4548 UM-ONC_1325-Mylotarg-gemtuzumab-ozogamicin_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6659 UM-ONC_1325-Mylotarg-gemtuzumab-ozogamicin_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24242 UM-ONC_1325-Mylotarg-gemtuzumab-ozogamicin_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31572 UM-ONC_1325-Mylotarg-gemtuzumab-ozogamicin_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 235728 UM-ONC_1325-Mylotarg-gemtuzumab-ozogamicin_12112019_cobranded.pdf
8/14/2025 1:56 PM 4567 UM-ONC_1326-Vyxeos-daunorubicin-and-cytarabine-liposomal_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6638 UM-ONC_1326-Vyxeos-daunorubicin-and-cytarabine-liposomal_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23880 UM-ONC_1326-Vyxeos-daunorubicin-and-cytarabine-liposomal_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32292 UM-ONC_1326-Vyxeos-daunorubicin-and-cytarabine-liposomal_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 227702 UM-ONC_1326-Vyxeos-daunorubicin-and-cytarabine-liposomal_12112019_cobranded.pdf
8/14/2025 1:56 PM 4493 UM-ONC_1327-Aliqopa-copanlisib_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6442 UM-ONC_1327-Aliqopa-copanlisib_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24001 UM-ONC_1327-Aliqopa-copanlisib_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 29978 UM-ONC_1327-Aliqopa-copanlisib_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 228392 UM-ONC_1327-Aliqopa-copanlisib_12112019_cobranded.pdf
8/14/2025 1:56 PM 4527 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6602 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23644 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31795 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 236350 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-1.pdf
8/18/2020 8:39 PM 4527 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6602 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23644 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31795 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 236350 UM-ONC_1328-Verzenio-abemaciclib_12112019_cobranded.pdf
8/14/2025 1:56 PM 4502 UM-ONC_1329-Yescarta-axicabtagene-ciloleucel_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6568 UM-ONC_1329-Yescarta-axicabtagene-ciloleucel_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23919 UM-ONC_1329-Yescarta-axicabtagene-ciloleucel_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31803 UM-ONC_1329-Yescarta-axicabtagene-ciloleucel_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 227437 UM-ONC_1329-Yescarta-axicabtagene-ciloleucel_06262020_cobranded.pdf
8/14/2025 1:56 PM 5465 UM-ONC_1330-Besponsa-inotuzumab-ozogamicin_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 7597 UM-ONC_1330-Besponsa-inotuzumab-ozogamicin_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24922 UM-ONC_1330-Besponsa-inotuzumab-ozogamicin_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32708 UM-ONC_1330-Besponsa-inotuzumab-ozogamicin_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 233968 UM-ONC_1330-Besponsa-inotuzumab-ozogamicin_04242020_cobranded.pdf
8/18/2020 8:39 PM 4540 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6633 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23950 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31622 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 207117 UM-ONC_1331-Calquence-acalabrutinib_05292020_cobranded.pdf
8/14/2025 1:56 PM 4650 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6768 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 25699 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 34987 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020-pdf.jpg
8/14/2025 1:56 PM 218631 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020.pdf
8/14/2025 1:56 PM 4631 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6760 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 25679 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35451 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 217322 UM-ONC_1332-Lutathera-lutetium-Lu-177-dotatate_03012020_cobranded.pdf
8/18/2020 8:39 PM 4605 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6779 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24653 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32188 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 226532 UM-ONC_1333-Erleada-apalutamide_07312020_cobranded.pdf
8/18/2020 8:39 PM 4464 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6516 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24041 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32030 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 208104 UM-ONC_1334-Doptelet-avatrombopag_12112019_cobranded.pdf
8/14/2025 1:56 PM 4589 UM-ONC_1335-Braftovi-encorafenib_05292020-pdf-116x150.jpg
8/14/2025 1:56 PM 6676 UM-ONC_1335-Braftovi-encorafenib_05292020-pdf-232x300.jpg
8/14/2025 1:56 PM 23839 UM-ONC_1335-Braftovi-encorafenib_05292020-pdf-791x1024.jpg
8/14/2025 1:56 PM 32078 UM-ONC_1335-Braftovi-encorafenib_05292020-pdf.jpg
8/14/2025 1:56 PM 224885 UM-ONC_1335-Braftovi-encorafenib_05292020.pdf
8/14/2025 1:56 PM 4526 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6644 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23530 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31736 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 223575 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-1.pdf
8/18/2020 8:39 PM 4526 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6644 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23530 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31736 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 223575 UM-ONC_1335-Braftovi-encorafenib_05292020_cobranded.pdf
8/14/2025 1:56 PM 221036 UM-ONC_1340-Tibosovo-ivosidenib_07312020-.pdf
8/14/2025 1:56 PM 4568 UM-ONC_1340-Tibosovo-ivosidenib_07312020-pdf-116x150.jpg
8/14/2025 1:56 PM 6664 UM-ONC_1340-Tibosovo-ivosidenib_07312020-pdf-232x300.jpg
8/14/2025 1:56 PM 24357 UM-ONC_1340-Tibosovo-ivosidenib_07312020-pdf-791x1024.jpg
8/14/2025 1:56 PM 32062 UM-ONC_1340-Tibosovo-ivosidenib_07312020-pdf.jpg
8/14/2025 1:56 PM 4562 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6615 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24335 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 32017 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 219933 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-1.pdf
8/18/2020 8:39 PM 4562 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6615 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24335 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32017 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded-pdf.jpg
8/18/2020 8:39 PM 219933 UM-ONC_1340-Tibosovo-ivosidenib_07312020_cobranded.pdf
8/14/2025 1:56 PM 4506 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6535 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23681 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31751 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 222197 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-1.pdf
8/18/2020 8:39 PM 4506 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6535 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23681 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31751 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 222197 UM-ONC_1341-Vizimpro-dacomitinib_12112019_cobranded.pdf
8/14/2025 1:56 PM 4508 UM-ONC_1342-Azedra-iobenguane-I-131_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6474 UM-ONC_1342-Azedra-iobenguane-I-131_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23889 UM-ONC_1342-Azedra-iobenguane-I-131_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31048 UM-ONC_1342-Azedra-iobenguane-I-131_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 220512 UM-ONC_1342-Azedra-iobenguane-I-131_06262020_cobranded.pdf
8/18/2020 8:39 PM 4548 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6614 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24155 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32107 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 223780 UM-ONC_1343-Mulpleta-lusutrombopag_12112019_cobranded.pdf
8/14/2025 1:56 PM 4510 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6571 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23881 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31494 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 219817 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_05292020_cobranded.pdf
8/14/2025 1:56 PM 5401 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_10302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9327 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_10302020-pdf-232x300.jpg
8/14/2025 1:56 PM 44776 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_10302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 63477 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_10302020-pdf.jpg
8/14/2025 1:56 PM 208767 UM-ONC_1344-Poteligeo-mogamulizumab-kpkc_10302020.pdf
8/14/2025 1:56 PM 4540 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6634 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23532 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31782 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 224077 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-1.pdf
8/18/2020 8:39 PM 4540 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6634 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23532 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31782 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:39 PM 224077 UM-ONC_1345-Tavalisse-fostamatinib_06262020_cobranded.pdf
8/14/2025 1:56 PM 4503 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6549 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23925 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31127 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 234971 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-1.pdf
8/18/2020 8:39 PM 4503 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6549 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23925 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31127 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded-pdf.jpg
8/18/2020 8:39 PM 234971 UM-ONC_1346-Copiktra-duvelisib_12112019_cobranded.pdf
8/14/2025 1:56 PM 4529 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6571 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23904 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31886 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 223682 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-1.pdf
8/18/2020 8:39 PM 4529 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6571 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23904 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 31886 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 223682 UM-ONC_1347-Lorbrena-lorlatinib_05292020_cobranded.pdf
8/14/2025 1:56 PM 4510 UM-ONC_1348-Lumoxiti-moxetumomab-pasudotox_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6571 UM-ONC_1348-Lumoxiti-moxetumomab-pasudotox_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23881 UM-ONC_1348-Lumoxiti-moxetumomab-pasudotox_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31494 UM-ONC_1348-Lumoxiti-moxetumomab-pasudotox_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 226245 UM-ONC_1348-Lumoxiti-moxetumomab-pasudotox_12112019_cobranded.pdf
8/14/2025 1:56 PM 4573 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6651 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24121 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 32171 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 217789 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-1.pdf
8/18/2020 8:39 PM 4573 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6651 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 24121 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32171 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded-pdf.jpg
8/18/2020 8:39 PM 217789 UM-ONC_1349-Talzenna-talazoparib_05292020_cobranded.pdf
8/14/2025 1:56 PM 4543 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6669 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23499 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 32266 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 237678 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-1.pdf
8/18/2020 8:39 PM 4543 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6669 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 23499 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 32266 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded-pdf.jpg
8/18/2020 8:39 PM 237678 UM-ONC_1350-Vitrakvi-larotrectinib_04242020_cobranded.pdf
8/14/2025 1:56 PM 220190 UM-ONC_1351-Xospata-Gilteritinib_03012020-.pdf
8/14/2025 1:56 PM 4671 UM-ONC_1351-Xospata-Gilteritinib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 7079 UM-ONC_1351-Xospata-Gilteritinib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26852 UM-ONC_1351-Xospata-Gilteritinib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35699 UM-ONC_1351-Xospata-Gilteritinib_03012020-pdf.jpg
8/14/2025 1:56 PM 4632 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 7068 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26701 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35811 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 219222 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-1.pdf
8/18/2020 8:39 PM 4632 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 7068 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 26701 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 35811 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded-pdf.jpg
8/18/2020 8:39 PM 219222 UM-ONC_1351-Xospata-Gilteritinib_03012020_cobranded.pdf
8/14/2025 1:56 PM 4736 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6960 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26439 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 36264 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020-pdf.jpg
8/14/2025 1:56 PM 219474 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020.pdf
8/14/2025 1:56 PM 4693 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6882 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 27066 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35835 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 218454 UM-ONC_1352-Asparlas-calaspargase-pegol-mknl_03012020_cobranded.pdf
8/14/2025 1:56 PM 4738 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6987 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 27287 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35968 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020-pdf.jpg
8/14/2025 1:56 PM 228532 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020.pdf
8/14/2025 1:56 PM 4722 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 7027 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26548 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35352 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 227615 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-1.pdf
8/14/2025 1:56 PM 4722 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-2-pdf-116x150.jpg
8/14/2025 1:56 PM 7027 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-2-pdf-232x300.jpg
8/14/2025 1:56 PM 26548 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-2-pdf-791x1024.jpg
8/14/2025 1:56 PM 35352 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-2-pdf.jpg
8/14/2025 1:56 PM 227615 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-2.pdf
8/18/2020 8:39 PM 4722 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 7027 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 26548 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 35352 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded-pdf.jpg
8/18/2020 8:39 PM 227615 UM-ONC_1353-Cablivi-caplacizumab-yhdp_03012020_cobranded.pdf
8/14/2025 1:56 PM 221073 UM-ONC_1354-Daurismo-glasdegib_03012020-.pdf
8/14/2025 1:56 PM 4738 UM-ONC_1354-Daurismo-glasdegib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6996 UM-ONC_1354-Daurismo-glasdegib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26215 UM-ONC_1354-Daurismo-glasdegib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 34223 UM-ONC_1354-Daurismo-glasdegib_03012020-pdf.jpg
8/14/2025 1:56 PM 4668 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6900 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26532 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35879 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 220073 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-1.pdf
8/18/2020 8:39 PM 4668 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:39 PM 6900 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:39 PM 26532 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:39 PM 35879 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded-pdf.jpg
8/18/2020 8:39 PM 220073 UM-ONC_1354-Daurismo-glasdegib_03012020_cobranded.pdf
8/14/2025 1:56 PM 4561 UM-ONC_1356-Elzonris-tagraxofusp_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6616 UM-ONC_1356-Elzonris-tagraxofusp_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24375 UM-ONC_1356-Elzonris-tagraxofusp_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32113 UM-ONC_1356-Elzonris-tagraxofusp_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 200572 UM-ONC_1356-Elzonris-tagraxofusp_06262020_cobranded.pdf
8/14/2025 1:56 PM 4501 UM-ONC_1359-Arranon-nelarabine_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6531 UM-ONC_1359-Arranon-nelarabine_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23042 UM-ONC_1359-Arranon-nelarabine_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31046 UM-ONC_1359-Arranon-nelarabine_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 219518 UM-ONC_1359-Arranon-nelarabine_06262020_cobranded.pdf
8/14/2025 1:56 PM 4573 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6641 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24263 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 30325 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 217667 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-1.pdf
8/18/2020 8:37 PM 4573 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6641 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24263 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30325 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 217667 UM-ONC_1360-Piqray-alpelisib_06262020_cobranded.pdf
8/14/2025 1:56 PM 4548 UM-ONC_1361-Erwinaze-asparaginase-Erwinia-chrysanthemi_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6617 UM-ONC_1361-Erwinaze-asparaginase-Erwinia-chrysanthemi_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23851 UM-ONC_1361-Erwinaze-asparaginase-Erwinia-chrysanthemi_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32075 UM-ONC_1361-Erwinaze-asparaginase-Erwinia-chrysanthemi_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 219689 UM-ONC_1361-Erwinaze-asparaginase-Erwinia-chrysanthemi_06262020_cobranded.pdf
8/14/2025 1:56 PM 4546 UM-ONC_1362-Polivy-polatuzumab-vedotin_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6626 UM-ONC_1362-Polivy-polatuzumab-vedotin_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24215 UM-ONC_1362-Polivy-polatuzumab-vedotin_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32386 UM-ONC_1362-Polivy-polatuzumab-vedotin_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 221355 UM-ONC_1362-Polivy-polatuzumab-vedotin_04242020_cobranded.pdf
8/18/2020 8:37 PM 4567 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6628 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24180 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32148 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 226252 UM-ONC_1363-Nubeqa-darolutamide_07312020_cobranded.pdf
8/14/2025 1:56 PM 4520 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6522 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23882 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 32374 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 219556 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-1.pdf
8/18/2020 8:37 PM 4520 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6522 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23882 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32374 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 219556 UM-ONC_1364-Turalio-pexidartinib_06262020_cobranded.pdf
8/14/2025 1:56 PM 4527 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6621 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24482 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 32577 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 220894 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-1.pdf
8/18/2020 8:37 PM 4527 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6621 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24482 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32577 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 220894 UM-ONC_1365-Xpovio-selinexor_07312020_cobranded.pdf
8/14/2025 1:56 PM 4522 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6579 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24327 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31279 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 224312 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-1.pdf
8/18/2020 8:37 PM 4522 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6579 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24327 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31279 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 224312 UM-ONC_1366-Inrebic-fedratinib_04242020_cobranded.pdf
8/14/2025 1:56 PM 4537 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6665 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23359 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31472 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 208826 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-1.pdf
8/18/2020 8:37 PM 4537 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6665 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23359 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31472 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded-pdf.jpg
8/18/2020 8:37 PM 208826 UM-ONC_1367-Rozlytrek-entrectinib_04242020_cobranded.pdf
8/14/2025 1:56 PM 4518 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6532 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24440 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31470 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 219029 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-1.pdf
8/18/2020 8:37 PM 4518 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6532 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24440 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31470 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded-pdf.jpg
8/18/2020 8:37 PM 219029 UM-ONC_1373-Endari-l-glutamine_12112019_cobranded.pdf
8/14/2025 1:56 PM 4524 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6614 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23631 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31085 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 244409 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-1.pdf
8/18/2020 8:37 PM 4524 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6614 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23631 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31085 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 244409 UM-ONC_1374-Balversa-erdafitinib_05292020_cobranded.pdf
8/14/2025 1:56 PM 4538 UM-ONC_1375-Adakveo-crizanlizumab_12112019_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6635 UM-ONC_1375-Adakveo-crizanlizumab_12112019_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23606 UM-ONC_1375-Adakveo-crizanlizumab_12112019_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 29916 UM-ONC_1375-Adakveo-crizanlizumab_12112019_cobranded-pdf.jpg
8/14/2025 1:56 PM 220485 UM-ONC_1375-Adakveo-crizanlizumab_12112019_cobranded.pdf
8/14/2025 1:56 PM 4492 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6504 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23925 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 30847 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 220268 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-1.pdf
8/18/2020 8:37 PM 4492 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6504 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23925 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30847 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 220268 UM-ONC_1376-Oxbryta-voxelotor_05292020_cobranded.pdf
8/14/2025 1:56 PM 235797 UM-ONC_1377-Brukinsa-zanubrutinib_01082020-.pdf
8/14/2025 1:56 PM 4706 UM-ONC_1377-Brukinsa-zanubrutinib_01082020-pdf-116x150.jpg
8/14/2025 1:56 PM 7048 UM-ONC_1377-Brukinsa-zanubrutinib_01082020-pdf-232x300.jpg
8/14/2025 1:56 PM 25971 UM-ONC_1377-Brukinsa-zanubrutinib_01082020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35793 UM-ONC_1377-Brukinsa-zanubrutinib_01082020-pdf.jpg
8/14/2025 1:56 PM 4695 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 7019 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 25988 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35081 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 232650 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-1.pdf
8/18/2020 8:37 PM 4695 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 7019 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 25988 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35081 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded-pdf.jpg
8/18/2020 8:37 PM 232650 UM-ONC_1377-Brukinsa-zanubrutinib_01082020_cobranded.pdf
8/14/2025 1:56 PM 4676 UM-ONC_1378-Ayvakit-avapritinib_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6858 UM-ONC_1378-Ayvakit-avapritinib_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26310 UM-ONC_1378-Ayvakit-avapritinib_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35393 UM-ONC_1378-Ayvakit-avapritinib_03012020-pdf.jpg
8/14/2025 1:56 PM 223598 UM-ONC_1378-Ayvakit-avapritinib_03012020.pdf
8/14/2025 1:56 PM 4627 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6817 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26285 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35372 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 222287 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-1.pdf
8/18/2020 8:37 PM 4627 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6817 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 26285 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35372 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 222287 UM-ONC_1378-Ayvakit-avapritinib_03012020_cobranded.pdf
8/14/2025 1:56 PM 4658 UM-ONC_1379-Enhertu-fam-trastuzumab-deruxtecan-nxki_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6932 UM-ONC_1379-Enhertu-fam-trastuzumab-deruxtecan-nxki_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 25774 UM-ONC_1379-Enhertu-fam-trastuzumab-deruxtecan-nxki_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35033 UM-ONC_1379-Enhertu-fam-trastuzumab-deruxtecan-nxki_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 220381 UM-ONC_1379-Enhertu-fam-trastuzumab-deruxtecan-nxki_03012020_cobranded.pdf
8/14/2025 1:56 PM 4671 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6910 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26387 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35771 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020-pdf.jpg
8/14/2025 1:56 PM 238174 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020.pdf
8/14/2025 1:56 PM 4625 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6846 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 26269 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35016 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 236931 UM-ONC_1380-Gamifant-emapalumab-lzsg_03012020_cobranded.pdf
8/14/2025 1:56 PM 4680 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6907 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 25723 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35644 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020-pdf.jpg
8/14/2025 1:56 PM 221547 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020.pdf
8/14/2025 1:56 PM 4636 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6787 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 26215 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32683 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 220308 UM-ONC_1381-Padcev-enfortumab-vedotin-ejfv_03012020_cobranded.pdf
8/14/2025 1:56 PM 4656 UM-ONC_1382-Soliris-eculizumab_03012020-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6905 UM-ONC_1382-Soliris-eculizumab_03012020-1-pdf-232x300.jpg
8/14/2025 1:56 PM 25903 UM-ONC_1382-Soliris-eculizumab_03012020-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35285 UM-ONC_1382-Soliris-eculizumab_03012020-1-pdf.jpg
8/14/2025 1:56 PM 229525 UM-ONC_1382-Soliris-eculizumab_03012020-1.pdf
8/14/2025 1:56 PM 4656 UM-ONC_1382-Soliris-eculizumab_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6905 UM-ONC_1382-Soliris-eculizumab_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 25903 UM-ONC_1382-Soliris-eculizumab_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35285 UM-ONC_1382-Soliris-eculizumab_03012020-pdf.jpg
8/14/2025 1:56 PM 229525 UM-ONC_1382-Soliris-eculizumab_03012020.pdf
8/14/2025 1:56 PM 4666 UM-ONC_1382-Soliris-eculizumab_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6916 UM-ONC_1382-Soliris-eculizumab_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 26284 UM-ONC_1382-Soliris-eculizumab_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35909 UM-ONC_1382-Soliris-eculizumab_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 228020 UM-ONC_1382-Soliris-eculizumab_03012020_cobranded.pdf
8/14/2025 1:56 PM 4676 UM-ONC_1383-Sylvant-siltuximab_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6893 UM-ONC_1383-Sylvant-siltuximab_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26182 UM-ONC_1383-Sylvant-siltuximab_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 33666 UM-ONC_1383-Sylvant-siltuximab_03012020-pdf.jpg
8/14/2025 1:56 PM 271952 UM-ONC_1383-Sylvant-siltuximab_03012020.pdf
8/14/2025 1:56 PM 4636 UM-ONC_1383-Sylvant-siltuximab_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6812 UM-ONC_1383-Sylvant-siltuximab_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 26237 UM-ONC_1383-Sylvant-siltuximab_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35648 UM-ONC_1383-Sylvant-siltuximab_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 270549 UM-ONC_1383-Sylvant-siltuximab_03012020_cobranded.pdf
8/14/2025 1:56 PM 4670 UM-ONC_1384-Targretin-bexarotene_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6923 UM-ONC_1384-Targretin-bexarotene_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26202 UM-ONC_1384-Targretin-bexarotene_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35814 UM-ONC_1384-Targretin-bexarotene_03012020-pdf.jpg
8/14/2025 1:56 PM 223709 UM-ONC_1384-Targretin-bexarotene_03012020.pdf
8/14/2025 1:56 PM 4628 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6849 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26482 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35317 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 222468 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-1.pdf
8/18/2020 8:37 PM 4628 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6849 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 26482 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35317 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded-pdf.jpg
8/18/2020 8:37 PM 222468 UM-ONC_1384-Targretin-bexarotene_03012020_cobranded.pdf
8/14/2025 1:56 PM 4540 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6665 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23702 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31677 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 227936 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-1.pdf
8/18/2020 8:37 PM 4540 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6665 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23702 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31677 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 227936 UM-ONC_1385-Tazverik-tazemetostat_07312020_cobranded.pdf
8/14/2025 1:56 PM 228645 UM-ONC_1386-Ultomiris-ravulizumab_03012020-.pdf
8/14/2025 1:56 PM 4675 UM-ONC_1386-Ultomiris-ravulizumab_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6888 UM-ONC_1386-Ultomiris-ravulizumab_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26307 UM-ONC_1386-Ultomiris-ravulizumab_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35523 UM-ONC_1386-Ultomiris-ravulizumab_03012020-pdf.jpg
8/14/2025 1:56 PM 4636 UM-ONC_1386-Ultomiris-ravulizumab_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6827 UM-ONC_1386-Ultomiris-ravulizumab_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 25814 UM-ONC_1386-Ultomiris-ravulizumab_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35298 UM-ONC_1386-Ultomiris-ravulizumab_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 227272 UM-ONC_1386-Ultomiris-ravulizumab_03012020_cobranded.pdf
8/14/2025 1:56 PM 4689 UM-ONC_1387-Unituxin-dinutuximab_03012020-pdf-116x150.jpg
8/14/2025 1:56 PM 6954 UM-ONC_1387-Unituxin-dinutuximab_03012020-pdf-232x300.jpg
8/14/2025 1:56 PM 26193 UM-ONC_1387-Unituxin-dinutuximab_03012020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35721 UM-ONC_1387-Unituxin-dinutuximab_03012020-pdf.jpg
8/14/2025 1:56 PM 306402 UM-ONC_1387-Unituxin-dinutuximab_03012020.pdf
8/14/2025 1:56 PM 4651 UM-ONC_1387-Unituxin-dinutuximab_03012020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6789 UM-ONC_1387-Unituxin-dinutuximab_03012020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 26668 UM-ONC_1387-Unituxin-dinutuximab_03012020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 35758 UM-ONC_1387-Unituxin-dinutuximab_03012020_cobranded-pdf.jpg
8/14/2025 1:56 PM 304961 UM-ONC_1387-Unituxin-dinutuximab_03012020_cobranded.pdf
8/14/2025 1:56 PM 4582 UM-ONC_1391-Thalomid-thalidomide_03272020-pdf-116x150.jpg
8/14/2025 1:56 PM 6909 UM-ONC_1391-Thalomid-thalidomide_03272020-pdf-232x300.jpg
8/14/2025 1:56 PM 26177 UM-ONC_1391-Thalomid-thalidomide_03272020-pdf-791x1024.jpg
8/14/2025 1:56 PM 35802 UM-ONC_1391-Thalomid-thalidomide_03272020-pdf.jpg
8/14/2025 1:56 PM 198863 UM-ONC_1391-Thalomid-thalidomide_03272020.pdf
8/14/2025 1:56 PM 4488 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6951 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 26223 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 35585 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 197618 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-1.pdf
8/18/2020 8:37 PM 4488 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6951 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 26223 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 35585 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded-pdf.jpg
8/18/2020 8:37 PM 197618 UM-ONC_1391-Thalomid-thalidomide_03272020_cobranded.pdf
8/14/2025 1:56 PM 4572 UM-ONC_1392-Reblozyl-luspatercept-aamt_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6645 UM-ONC_1392-Reblozyl-luspatercept-aamt_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24202 UM-ONC_1392-Reblozyl-luspatercept-aamt_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32408 UM-ONC_1392-Reblozyl-luspatercept-aamt_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 225274 UM-ONC_1392-Reblozyl-luspatercept-aamt_04242020_cobranded.pdf
8/14/2025 1:56 PM 4498 UM-ONC_1393-Sarclisa-isatuximab-irfc_04242020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6562 UM-ONC_1393-Sarclisa-isatuximab-irfc_04242020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24182 UM-ONC_1393-Sarclisa-isatuximab-irfc_04242020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 30764 UM-ONC_1393-Sarclisa-isatuximab-irfc_04242020_cobranded-pdf.jpg
8/14/2025 1:56 PM 224645 UM-ONC_1393-Sarclisa-isatuximab-irfc_04242020_cobranded.pdf
8/14/2025 1:56 PM 4499 UM-ONC_1395-Clolar-clofarabine_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6555 UM-ONC_1395-Clolar-clofarabine_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24029 UM-ONC_1395-Clolar-clofarabine_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31704 UM-ONC_1395-Clolar-clofarabine_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 216456 UM-ONC_1395-Clolar-clofarabine_05292020_cobranded.pdf
8/14/2025 1:56 PM 4582 UM-ONC_1396-Koselugo-selumetinib_05292020-pdf-116x150.jpg
8/14/2025 1:56 PM 6656 UM-ONC_1396-Koselugo-selumetinib_05292020-pdf-232x300.jpg
8/14/2025 1:56 PM 24142 UM-ONC_1396-Koselugo-selumetinib_05292020-pdf-791x1024.jpg
8/14/2025 1:56 PM 32013 UM-ONC_1396-Koselugo-selumetinib_05292020-pdf.jpg
8/14/2025 1:56 PM 217935 UM-ONC_1396-Koselugo-selumetinib_05292020.pdf
8/14/2025 1:56 PM 4559 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6614 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24041 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31886 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 216842 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-1.pdf
8/18/2020 8:37 PM 4559 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6614 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24041 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31886 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 216842 UM-ONC_1396-Koselugo-selumetinib_05292020_cobranded.pdf
8/14/2025 1:56 PM 5270 UM-ONC_1396-Koselugo-selumetinib_11302020-pdf-116x150.jpg
8/14/2025 1:56 PM 9116 UM-ONC_1396-Koselugo-selumetinib_11302020-pdf-232x300.jpg
8/14/2025 1:56 PM 42793 UM-ONC_1396-Koselugo-selumetinib_11302020-pdf-791x1024.jpg
8/14/2025 1:56 PM 60330 UM-ONC_1396-Koselugo-selumetinib_11302020-pdf.jpg
8/14/2025 1:56 PM 207297 UM-ONC_1396-Koselugo-selumetinib_11302020.pdf
8/14/2025 1:56 PM 4517 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6586 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23597 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31611 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 223792 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-1.pdf
8/18/2020 8:37 PM 4517 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6586 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23597 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31611 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 223792 UM-ONC_1397-Mektovi-binimetinib_05292020_cobranded.pdf
8/14/2025 1:56 PM 4570 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6652 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23845 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31689 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 219428 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-1.pdf
8/18/2020 8:37 PM 4570 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6652 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23845 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31689 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded-pdf.jpg
8/18/2020 8:37 PM 219428 UM-ONC_1398-Pemazyre-pemigatinib_05292020_cobranded.pdf
8/14/2025 1:56 PM 4538 UM-ONC_1399-Photofrin-porfimer_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6636 UM-ONC_1399-Photofrin-porfimer_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23335 UM-ONC_1399-Photofrin-porfimer_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 31639 UM-ONC_1399-Photofrin-porfimer_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 214752 UM-ONC_1399-Photofrin-porfimer_05292020_cobranded.pdf
8/14/2025 1:56 PM 4578 UM-ONC_1400-Tepadina-thiotepa_05292020-pdf-116x150.jpg
8/14/2025 1:56 PM 6687 UM-ONC_1400-Tepadina-thiotepa_05292020-pdf-232x300.jpg
8/14/2025 1:56 PM 24267 UM-ONC_1400-Tepadina-thiotepa_05292020-pdf-791x1024.jpg
8/14/2025 1:56 PM 32262 UM-ONC_1400-Tepadina-thiotepa_05292020-pdf.jpg
8/14/2025 1:56 PM 216870 UM-ONC_1400-Tepadina-thiotepa_05292020.pdf
8/14/2025 1:56 PM 4520 UM-ONC_1400-Tepadina-thiotepa_05292020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6523 UM-ONC_1400-Tepadina-thiotepa_05292020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 23886 UM-ONC_1400-Tepadina-thiotepa_05292020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 29907 UM-ONC_1400-Tepadina-thiotepa_05292020_cobranded-pdf.jpg
8/14/2025 1:56 PM 215824 UM-ONC_1400-Tepadina-thiotepa_05292020_cobranded.pdf
8/14/2025 1:56 PM 4496 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6509 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24004 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 31623 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 220917 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-1.pdf
8/18/2020 8:37 PM 4496 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6509 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24004 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 31623 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded-pdf.jpg
8/18/2020 8:37 PM 220917 UM-ONC_1401-Tukysa-tucatinib_07312020_cobranded.pdf
8/14/2025 1:56 PM 4518 UM-ONC_1403-Elitek-rasburicase_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6551 UM-ONC_1403-Elitek-rasburicase_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24128 UM-ONC_1403-Elitek-rasburicase_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 32203 UM-ONC_1403-Elitek-rasburicase_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 221200 UM-ONC_1403-Elitek-rasburicase_06262020_cobranded.pdf
8/14/2025 1:56 PM 4534 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6600 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23976 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 30420 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 221328 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-1.pdf
8/18/2020 8:37 PM 4534 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6600 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23976 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30420 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 221328 UM-ONC_1404-Qinlock-ripretinib_06262020_cobranded.pdf
8/14/2025 1:56 PM 4518 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6605 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 23940 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 30468 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 222700 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-1.pdf
8/18/2020 8:37 PM 4518 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6605 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 23940 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 30468 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 222700 UM-ONC_1405-Retevmo-selpercatinib_06262020_cobranded.pdf
8/14/2025 1:56 PM 4569 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-1-pdf-116x150.jpg
8/14/2025 1:56 PM 6627 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-1-pdf-232x300.jpg
8/14/2025 1:56 PM 24265 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-1-pdf-791x1024.jpg
8/14/2025 1:56 PM 32112 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-1-pdf.jpg
8/14/2025 1:56 PM 219783 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-1.pdf
8/18/2020 8:37 PM 4569 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf-116x150.jpg
8/18/2020 8:37 PM 6627 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf-232x300.jpg
8/18/2020 8:37 PM 24265 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf-791x1024.jpg
8/18/2020 8:37 PM 32112 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded-pdf.jpg
8/18/2020 8:37 PM 219783 UM-ONC_1406-Tabrecta-capmatinib_06262020_cobranded.pdf
8/14/2025 1:56 PM 4512 UM-ONC_1407-Trodelvy-govitecan-hziy_06262020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6536 UM-ONC_1407-Trodelvy-govitecan-hziy_06262020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24223 UM-ONC_1407-Trodelvy-govitecan-hziy_06262020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 29532 UM-ONC_1407-Trodelvy-govitecan-hziy_06262020_cobranded-pdf.jpg
8/14/2025 1:56 PM 224926 UM-ONC_1407-Trodelvy-govitecan-hziy_06262020_cobranded.pdf
8/14/2025 1:56 PM 4531 UM-ONC_1408-Zepzelca-lurbinectedin_07312020_cobranded-pdf-116x150.jpg
8/14/2025 1:56 PM 6641 UM-ONC_1408-Zepzelca-lurbinectedin_07312020_cobranded-pdf-232x300.jpg
8/14/2025 1:56 PM 24103 UM-ONC_1408-Zepzelca-lurbinectedin_07312020_cobranded-pdf-791x1024.jpg
8/14/2025 1:56 PM 30923 UM-ONC_1408-Zepzelca-lurbinectedin_07312020_cobranded-pdf.jpg
8/14/2025 1:56 PM 217652 UM-ONC_1408-Zepzelca-lurbinectedin_07312020_cobranded.pdf
8/14/2025 1:56 PM 6811 WorkflowofaRequest-NCH-pdf-116x150.jpg
8/14/2025 1:56 PM 16106 WorkflowofaRequest-NCH-pdf-232x300.jpg
8/14/2025 1:56 PM 107044 WorkflowofaRequest-NCH-pdf-791x1024.jpg
8/14/2025 1:56 PM 161927 WorkflowofaRequest-NCH-pdf.jpg
8/14/2025 1:56 PM 540853 WorkflowofaRequest-NCH.pdf